Alastair Burt
Health and Medical Sciences Faculty Office
Faculty of Health and Medical Sciences
Emeritus Professor Alastair Burt
BSc (Hons), MBChB, MD (Hons), FRCPath, FRCP, FRCPA, FRSB, FAcadMEd, FAHMS
Alastair Burt was born in Dunfermline, Scotland and is a graduate of the University of Glasgow where he obtained a BSc in Pathology with First Class Honours in 1979, MBChB with Commendation in 1981 and MD with Honours and the Bellahouston Medal in 1991.
Upon graduation, he became Junior House Officer in General Medicine with Professor Sir Abraham Goldberg and Junior House Officer in Surgery with Professor Sir David Carter. He subsequently took up training in surgical pathology under the tutelage of Professor Sir Roddy MacSween. During this time, he developed expertise in diagnostic pathology of the liver and a keen interest in the pathogenesis of liver disease and in particular mechanisms of liver fibrosis. In 1985-86 he was a Peel Trust Fellow in the Lab for Cell Biology and Histology at Free University of Brussels under the direction of Professor Eddie Wisse. On return to the UK and completion of his postgraduate training in surgical pathology he moved to the University of Newcastle upon Tyne to become Senior Lecturer in Pathology and Honorary Consultant Histopathologist. He was promoted to a personal Chair in Hepatopathology in 1995 and then the established Chair of Pathology in 1998. He became Dean of Clinical Medicine at the University of Newcastle upon Tyne in 2005.
He moved to South Australia in January 2013 to take up the post of Dean of Medicine and Head of the School of Medicine. In August 2014, he became acting Executive Dean of the Faculty of Health and Medical Sciences and was appointed to the substantive role in December 2014. He continued to maintain an active research interest in liver disease and has published extensively in high quality peer-reviewed journals including Nature, Nature Medicine, Nature Communications, Lancet, N Engl J Med, Gastroenterology, Hepatology. He has an H index of 72 and over 20000 citations. He has secured over $8m in external grants and has supervised 16 HDR students to completion. He is Editor in Chief of the principal international text book in his field, MacSween’s Pathology of the Liver, now into its 7th edition. In addition, in 2018 he completed seven years as Editor in Chief of the peer reviewed journal, Histopathology. He was elected as a Fellow of the Australian Academy of Health and Medical Sciences in 2015.
As Executive Dean, he successfully led a number of major changes which include restructure of the Faculty, implementation of the most comprehensive Faculty-level professional services reform program in the institution, ‘reimagining’ of the Bachelor of Health Sciences and Psychological Sciences programs and the development of a new Bachelor/MD program in Medicine to achieve AQF level 9 status. He chaired the key governance groups for the development of the $240m Adelaide Health and Medical Sciences building which was officially opened in February 2017. He was a member of the Board of SAHMRI, the Executive of the SA Health Research and Translation Centre and Adelaide BioMed City Partners. He developed strong partnerships with key stakeholders in the health sector in particular SA Health and its networks and chaired the SA Clinical Training Council.
Emeritus Professor Burt retired from the role of Executive Dean on 1 March 2019 and now resides in the UK where he is Professor of Precision and Molecular Pathology at Newcastle University and Director of ADB Health Solutions. He is also Honorary Consultant Histopathologist in the Newcastle upon Tyne Hospitals NHS Foundation Trust and Director of NovoPath, the Newcastle MRC Node for Molecular Pathology and institutional lead for Precision Medicine, Genomics and Informatics. He is co-lead for one of the strand of Informatics for Precision Care the current Newcastle bid for NIHR BRC4 funding. He was recently awarded the Presidents's Medal from the British Division of the International Academy of Pathology. For the past two years he has (remotely) provided the liver biopsy service for Bart's and the London Hospital/QUML.
Research Interests
Professor Burt has a long standing interest in the pathogenesis of liver fibrosis. This is an important part of progressive liver disease and an essential component for the development of cirrhosis. He played a pivotal role in establishing the principal cell type involved in fibrogenesis is the hepatic stellate cell and was the first to characterise their cell kinetics in the response to injury establishing that there is not only proliferation of these cells in response to necrosis but a phenotypic modulation to myofibroblast-like cell. He was among the first to utilise isolated cell preparations of stellate cells to characterise in vitro properties such as collagen production and to examine the effects of cytokines responsible for activating these cells. In parallel with basic studies of fibrogenesis he has been involved in applied studies of surrogate markers of fibrogenesis and this has led to the development of algorithms of serum markers that represent an effective means of monitoring fibrosis in individual patients. He has attracted grant funding of over $8.5 million including awards from the MRC, Wellcome Trust and NIH. He played a key role on an FP7 EU grant on fatty liver disease leading a consortium tasked with redefining steatohepatitis for diagnostic epidemiological purposes. He has been editor or co-editor of eight textbooks, 22 book chapters and over 190 scientific publications. He has been supervisor or co-supervisor for 17 HDR students. He was a member of one of the panels of the UK RAE 2008 and was appointed to the REF 2014 exercise before moving to Australia.
He continues to be clinically active and has an appointment as a senior consultant anatomical pathologist with SA Pathology with responsibility for gastrointestinal and liver surgical pathologies. He has full registration with AHPRA. He is one of the senior members of the International Hepatopathology Group (Gnomes) an organisation which has been in existence since 1967 and which has been responsible for major classifications and diagnostic approaches to liver disease.
-
Appointments
Date Position Institution name 2019 - ongoing Professor of Precision and Molecular Pathology Newcsatle University 2019 - ongoing Emeritus Professor University of Adelaide 2014 - 2019 Executive Dean University of Adelaide 2014 - 2014 Acting Executive Dean University of Adelaide 2013 - 2014 Dean of Medicine and Head of School University of Adelaide 1998 - 2012 Established Chair of Pathology and Dean of Clinical Medicine (from 2005) University of Newcastle upon Tyne 1995 - 1998 Personal Professorship in Hepatopathology University of Newcastle upon Tyne 1989 - 1995 Senior Lecturer in Pathology University of Newcastle upon Tyne, Royal Victoria Infirmary 1986 - 1989 Registrar and Senior Registrar in Pathology Western Infirmary 1986 - 1986 Honorary Clinical Teacher University of Glasgow 1985 - 1986 Peel Travelling Research Fellow Free University of Brussels 1982 - 1985 Senior House Officer/Registrar in Pathology Western Infirmary 1982 - 1982 Junior House Officer in General Surgery Royal Infirmary 1981 - 1982 Junior House Officer in General Medicine Western Infirmary -
Awards and Achievements
Date Type Title Institution Name Country Amount 2014 Fellowship Royal College of Pathologists of Australasia - - - 2009 Fellowship Royal College of Physicians - United Kingdom - 2009 Fellowship Fellowship of the Royal College of Physicians (London) - - - 1997 Fellowship Fellowship of the Royal College of Pathologists - - - 1997 Fellowship Royal College of Pathologists - - - 1996 Fellowship Institute of Biologists - - - 1996 Fellowship Fellow of the Institute of Biologists (now Fellow of the Royal Society of Biologists) - - - 1993 Award Canterbury Medical Foundation Research Award University of Otago - - 1993 Achievement CL Oakley Lectureship Pathological Society of Great Britain and Ireland - - 1992 Award Bellahouston Medal University of Glasgow - - 1981 Award Agnes Cameron and Mary Margaret Isabel Ure Prize - - - 1981 Award John W Weir Prize - - - 1980 Award Glasgow University Medical Chirurgical Society Calman Trophy - - - -
Education
Date Institution name Country Title 1991 University of Glasgow United Kingdom M.D. with Honours and Medal 1981 University of Glasgow United Kingdom M.B. Ch.B. with Commendation 1979 University of Glasgow United Kingdom B.Sc. in Pathology with First Class Honours -
Certifications
Date Title Institution name Country 2015 Fellowship of the Australian Academy of Health and Medical Sciences Australian Academy of Health and Medical Sciences - 2015 Fellowship of Academy of Medical Educators Academy of Medical Educators - 2014 Fellowship of the Royal College of Pathologists of Australasia Royal College of Pathologists of Australasia - 2009 Fellowship of the Royal College of Physicians Royal College of Physicians - 2007 Foundation Member Academy Medical Educators - 1997 Fellowship of the Royal College of Pathologists Royal College of Pathologists - 1996 Fellowship of the Royal Society of Biologists Royal Society of Biologists - — Membership Royal College of Pathologists - — Membership Institute of Biologists -
-
Journals
Year Citation 2024 McGenity, C., Randell, R., Bellamy, C., Burt, A., Cratchley, A., Goldin, R., . . . Treanor, D. (2024). Survey of liver pathologists to assess attitudes towards digital pathology and artificial intelligence. Journal of Clinical Pathology, 77(1), 27-33.
Scopus4 WoS1 Europe PMC12024 McNeil, C., Wong, P. F., Sridhar, N., Wang, Y., Santori, C., Wu, C. H., . . . Cimermancic, P. (2024). An End-to-End Platform for Digital Pathology Using Hyperspectral Autofluorescence Microscopy and Deep Learning-Based Virtual Histology. Modern Pathology, 37(2), 12 pages.
Scopus4 Europe PMC22024 Armandi, A., Sanavia, T., Younes, R., Caviglia, G. P., Rosso, C., Govaere, O., . . . Bugianesi, E. (2024). Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease. Gut, 73(5), 825-834.
Scopus7 WoS1 Europe PMC32024 Clouston, A. D., Gouw, A. S. H., Tiniakos, D., Bedossa, P., Brunt, E. M., Callea, F., . . . Burt, A. D. (2024). Severe acute liver disease in adults: Contemporary role of histopathology. Histopathology, 85(4), 549-561.
2024 Soon, G. S. T., Callea, F., Burt, A. D., Cook, S., Terracciano, L., Ercan, C., . . . Torbenson, M. (2024). Steatohepatitic hepatocellular Carcinoma:A new approach to classifying morphological subtypes of hepatocellular carcinoma. Human Pathology, 149, 55-65.
2024 Vacca, M., Kamzolas, I., Harder, L. M., Oakley, F., Trautwein, C., Hatting, M., . . . Campbell, M. (2024). An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD). Nature Metabolism, 6(6), 1178-1196.
Scopus14 Europe PMC42024 Iyer, J. S., Juyal, D., Le, Q., Shanis, Z., Pokkalla, H., Pouryahya, M., . . . Beck, A. H. (2024). AI-based automation of enrollment criteria and endpoint assessment in clinical trials in liver diseases. Nature Medicine, 30(10), 22 pages.
Scopus12023 Burt, A. D. (2023). Augmented liver pathology: artificial intelligence and the assessment of hepatocellular neoplasms. Histopathology, 83(4), 509-511.
Scopus1 Europe PMC12023 Mózes, F. E., Lee, J. A., Vali, Y., Alzoubi, O., Staufer, K., Trauner, M., . . . Davies, S. (2023). Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis. The Lancet Gastroenterology and Hepatology, 8(8), 704-713.
Scopus69 Europe PMC332023 Iyer, J. S., Pokkalla, H., Biddle-Snead, C., Carrasco-Zevallos, O., Lin, M., Shanis, Z., . . . Wapinski, I. (2023). AI-based histologic scoring enables automated and reproducible assessment of enrollment criteria and endpoints in NASH clinical trials.. medRxiv.
2023 Anstee, Q. M., Darlay, R., Cockell, S., Meroni, M., Govaere, O., Tiniakos, D., . . . Daly, A. K. (2023). Corrigendum to: “Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort<sup>☆</sup>” [J Hepatol (2020) 505–515, (S0168827820302130), (10.1016/j.jhep.2020.04.003)]. Journal of Hepatology, 78(5), 1085-1086.
Scopus1 WoS12022 Geh, D., Watson, R., Sen, G., French, J. J., Hammond, J., Turner, P., . . . Reeves, H. L. (2022). COVID-19 and liver cancer: Lost patients and larger tumours. BMJ Open Gastroenterology, 9(1), 9 pages.
Scopus18 WoS13 Europe PMC162022 Zaki, M. Y. W., Alhasan, S. F., Shukla, R., McCain, M., Laszczewska, M., Geh, D., . . . Reeves, H. L. (2022). Sulfatase-2 from Cancer Associated Fibroblasts: An Environmental Target for Hepatocellular Carcinoma?. Liver Cancer, 11(6), 540-557.
Scopus7 WoS3 Europe PMC32022 Kobayashi, H., Gieniec, K. A., Lannagan, T. R., Wang, T., Asai, N., Mizutani, Y., . . . Worthley, D. L. (2022). The origin and contribution of cancer-associated fibroblasts in colorectal carcinogenesis. Gastroenterology, 162(3), 890-906.
Scopus85 WoS37 Europe PMC672022 Younes, R., Govaere, O., Petta, S., Miele, L., Tiniakos, D., Burt, A., . . . Bugianesi, E. (2022). Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?. Gut, 71(2), 382-390.
Scopus132 WoS91 Europe PMC782021 Anstee, Q. M., Darlay, R., Cockell, S., Meroni, M., Govaere, O., Tiniakos, D., . . . EPoS Consortium Investigators. (2021). Corrigendum to: "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort"☆ (J Hepatol [2020] 505-515).. Journal of hepatology, 74(5), 1274-1275.
Scopus3 WoS1 Europe PMC62021 Eldafashi, N., Darlay, R., Shukla, R., McCain, M. V., Watson, R., Liu, Y. L., . . . Reeves, H. L. (2021). A pdcd1 role in the genetic predisposition to nafld-hcc?. Cancers, 13(6), 1-17.
Scopus27 WoS20 Europe PMC242021 Younes, R., Caviglia, G. P., Govaere, O., Rosso, C., Armandi, A., Sanavia, T., . . . Bugianesi, E. (2021). Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease.. Journal of hepatology, 75(4), 786-794.
Scopus120 WoS74 Europe PMC672021 Connoley, D., Patel, P. J., Hogan, B., Tanwar, S., Rhodes, F., Parkes, J., . . . Rosenberg, W. (2021). The Enhanced Liver Fibrosis test maintains its diagnostic and prognostic performance in alcohol-related liver disease: a cohort study. BMC Gastroenterology, 21(1), 11 pages.
Scopus10 WoS3 Europe PMC22021 Torbenson, M., Desmet, V., Denk, H., Callea, F., Burt, A. D., Hübscher, S. G., . . . Tiniakos, D. (2021). Fifty years of impact on liver pathology: a history of the Gnomes. Virchows Archiv, 478(2), 191-200.
Scopus12021 Ireland, P. J., Hardy, T., Burt, A. D., & Donnelly, M. C. (2021). Drug-induced hepatocellular injury due to herbal supplement ashwagandha. Journal of the Royal College of Physicians of Edinburgh, 51(4), 363-365.
Scopus10 WoS3 Europe PMC42021 Kobayashi, H., Gieniec, K. A., Ng, J. Q., Goyne, J., Lannagan, T. R. M., Thomas, E. M., . . . Woods, S. L. (2021). Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma. Journal of Visualized Experiments, 2021(175), e62630-1-e62630-21.
Europe PMC12020 Connoley, D., Patel, P., Hogan, B., Tanwar, S., Rhodes, F., Parkes, J., . . . Rosenberg, W. (2020). The Enhanced Liver Fibrosis test maintains its diagnostic and prognostic performance in alcohol-related liver disease: A cohort study..
2020 Zorron Cheng Tao Pu, L., Yamamura, T., Nakamura, M., Koay, D. S. C., Ovenden, A., Edwards, S., . . . Singh, R. (2020). Comparison of different virtual chromoendoscopy classification systems for the characterization of colorectal lesions. JGH Open, 4(5), 818-826.
Scopus6 WoS3 Europe PMC22020 Zorron Cheng Tao Pu, L., Singh, G., Rana, K., Nakamura, M., Yamamura, T., Krishnamurthi, S., . . . Singh, R. (2020). Polyp Detection Rate as a Surrogate for Adenoma and Sessile Serrated Adenoma/Polyp Detection Rates.. Gastrointestinal tumors, 7(3), 74-82.
WoS4 Europe PMC62020 Hardy, T., Wonders, K., Younes, R., Aithal, G. P., Aller, R., Allison, M., . . . Anstee, Q. M. (2020). The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease. Contemporary Clinical Trials, 98, 11 pages.
Scopus81 WoS46 Europe PMC422020 Kobayashi, H., Gieniec, K. A., Wright, J. A., Wang, T., Asai, N., Mizutani, Y., . . . Woods, S. L. (2020). The Balance of stromal BMP signaling mediated by GREM1 and ISLR drives colorectal carcinogenesis. Gastroenterology, 160(4), 1224-1239.
Scopus86 WoS60 Europe PMC722020 Younes, R., Govaere, O., Petta, S., Miele, L., Tiniakos, D., Burt, A., . . . Bugianesi, E. (2020). Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease. American Journal of Gastroenterology, 115(8), 1289-1292.
Scopus11 WoS5 Europe PMC52020 Zorron Cheng Tao Pu, L., Rana, K., Singh, G., Nakamura, M., Yamamura, T., Koay, D. S. C., . . . Singh, R. (2020). Different factors are associated with conventional adenoma and serrated colorectal Neoplasia. Nagoya Journal of Medical Science, 82(2), 335-343.
Scopus3 WoS1 Europe PMC12020 Zorron Cheng Tao Pu, L., Yamamoto, K., Honda, T., Nakamura, M., Yamamura, T., Hattori, S., . . . Fujishiro, M. (2020). Microbiota profile is different for early and invasive colorectal cancer and is consistent throughout the colon. Journal of Gastroenterology and Hepatology (Australia), 35(3), 433-437.
Scopus39 WoS26 Europe PMC202020 Zorron Cheng Tao Pu, L., Yamamura, T., Nakamura, M., Esaki, M., Kaosombatwattana, U., Rodriguez, M. R., . . . Fujishiro, M. (2020). Learning curve for mastery of colorectal endoscopic submucosal dissection: Perspectives from a large Japanese cohort. JGH Open, 4(4), 611-616.
Scopus4 WoS3 Europe PMC22020 Cheng Tao Pu, L. Z., Maicas, G., Tian, Y., Yamamura, T., Nakamura, M., Suzuki, H., . . . Singh, R. (2020). Computer-aided diagnosis for characterisation of colorectal lesions: a comprehensive software including serrated lesions. Gastrointestinal Endoscopy, 92(4), 891-899.
Scopus37 WoS27 Europe PMC142020 Carneiro, G., Zorron Cheng Tao Pu, L., Singh, R., & Burt, A. (2020). Deep learning uncertainty and confidence calibration for the five-class polyp classification from colonoscopy. Medical Image Analysis, 62, 1-13.
Scopus51 WoS29 Europe PMC112020 Anstee, Q. M., Darlay, R., Cockell, S., Meroni, M., Govaere, O., Tiniakos, D., . . . EPoS Consortium Investigators. (2020). Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically-characterised cohort.. Journal of hepatology, 73(3), 505-515.
Scopus304 WoS201 Europe PMC1972019 Houghton, D., Zalewski, P., Hallsworth, K., Cassidy, S., Thoma, C., Avery, L., . . . Trenell, M. I. (2019). The degree of hepatic steatosis associates with impaired cardiac and autonomic function. Journal of Hepatology, 70(6), 1203-1213.
Scopus51 WoS37 Europe PMC272019 Brial, F., Le Lay, A., Hedjazi, L., Tsang, T., Fearnside, J. F., Otto, G. W., . . . Gauguier, D. (2019). Systems Genetics of Hepatic Metabolome Reveals Octopamine as a Target for Non-Alcoholic Fatty Liver Disease Treatment. Scientific Reports, 9(1), 10 pages.
Scopus9 WoS5 Europe PMC52019 Zorron Cheng Tao Pu, L., Lu, K., Ovenden, A., Rana, K., Singh, G., Krishnamurthi, S., . . . Singh, R. (2019). Effect of time of day and specialty on polyp detection rates in Australia. Journal of Gastroenterology and Hepatology, 34(5), 899-906.
Scopus9 WoS11 Europe PMC72019 Kobayashi, H., Enomoto, A., Woods, S. L., Burt, A. D., Takahashi, M., & Worthley, D. L. (2019). Cancer-associated fibroblasts in gastrointestinal cancer. Nature Reviews Gastroenterology and Hepatology, 16(5), 282-295.
Scopus390 WoS285 Europe PMC2922019 Zorron Cheng Tao Pu, L., Chiam, K. H., Yamamura, T., Nakamura, M., Berzin, T. M., Mir, F. F., . . . Singh, R. (2019). Narrow-band imaging for scar classification: from conception to multicenter validation.. Gastrointestinal endoscopy, 91(5), 14 pages.
Scopus11 WoS5 Europe PMC22018 Burt, A. D. (2018). A further change of the guard. Histopathology, 73(6), 876-877.
2018 Shalapour, S., Lin, X. J., Bastian, I. N., Brain, J., Burt, A. D., Aksenov, A. A., . . . Karin, M. (2018). Erratum to: Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity (Nature, (2017), 551, 7680, (340-345), 10.1038/nature24302). Nature, 561(7721), E1.
Scopus3 WoS3 Europe PMC22018 Burt, A. D., Alves, V., Bedossa, P., Clouston, A., Guido, M., Hübscher, S., . . . Ellis, D. W. (2018). Data set for the reporting of intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma and hepatocellular carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology, 73(3), 369-385.
Scopus36 WoS26 Europe PMC182017 Shalapour, S., Lin, X. -J., Bastian, I. N., Brain, J., Burt, A. D., Aksenov, A. A., . . . Karin, M. (2017). Inflammation-induced IgA⁺ cells dismantle anti-liver cancer immunity. Nature, 551(7680), 340-345.
Scopus381 WoS297 Europe PMC2802017 Ogrodnik, M., Miwa, S., Tchkonia, T., Tiniakos, D., Wilson, C., Lahat, A., . . . Jurk, D. (2017). Cellular senescence drives age-dependent hepatic steatosis. Nature Communications, 8(1), 15691-1-15691-12.
Scopus685 WoS540 Europe PMC4722017 Burt, A. D. (2017). Annual review issue: surgical pathology of 21st century medicine. Histopathology, 70(1), 3.
2017 McPherson, S., Hardy, T., Dufour, J., Petta, S., Romero-Gomez, M., Allison, M., . . . Anstee, Q. (2017). Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis. American Journal of Gastroenterology, 112(5), 740-751.
Scopus576 WoS418 Europe PMC3192017 Shalapour, S., Lin, X. -J., Bastian, I. N., Brain, J., Burt, A. D., Aksenov, A. A., . . . Karin, M. (2017). Erratum: Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity.. Nature, 552(7685), 430.
WoS4 Europe PMC32017 Burt, A. D. (2017). From this month's. HISTOPATHOLOGY, 71(1), 2 pages. 2017 Lackner, C., Bataller, R., Burt, A., Miquel, R., Schuppan, D., Tiniakos, D., & Trauner, M. (2017). Fibrosis evaluation by transient elastography in alcoholic liver disease: is the histological scoring system impacting cutoff values?. Hepatology, 65(5), 1758-1761.
Scopus5 WoS3 Europe PMC22017 McPherson, S., Wilkinson, N., Tiniakos, D., Wilkinson, J., Burt, A., McColl, E., . . . Day, C. (2017). A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis. PLoS ONE, 12(4), e0175717-1-e0175717-17.
Scopus47 WoS38 Europe PMC262017 Houghton, D., Thoma, C., Hallsworth, K., Cassidy, S., Hardy, T., Burt, A., . . . Trenell, M. (2017). Exercise Reduces Liver Lipids and Visceral Adiposity in Patients With Nonalcoholic Steatohepatitis in a Randomized Controlled Trial. Clinical Gastroenterology and Hepatology, 15(1), 96-102.e3.
Scopus158 WoS120 Europe PMC882016 Alhasan, S., Haugk, B., Ogle, L., Beale, G., Long, A., Burt, A., . . . Reeves, H. (2016). Sulfatase-2: A prognostic biomarker and candidate therapeutic target in patients with pancreatic ductal adenocarcinoma. British Journal of Cancer, 115(7), 797-804.
Scopus11 WoS13 Europe PMC112016 Munteanu, M., Tiniakos, D., Anstee, Q., Charlotte, F., Marchesini, G., Bugianesi, E., . . . Mercadier, A. (2016). Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference. Alimentary Pharmacology and Therapeutics, 44(8), 877-889.
Scopus80 WoS56 Europe PMC422016 Singh, R., Tao Pu, L. Z. C., Koay, D., & Burt, A. (2016). Sessile serrated adenoma/polyps: Where are we at in 2016?. World Journal of Gastroenterology, 22(34), 7754-7759.
Scopus33 WoS24 Europe PMC142016 Liew, V. Y., Chapman, M. J., Nguyen, N. Q., Cousins, C. E., Plummer, M. P., Chapple, L. A. S., . . . Deane, A. M. (2016). A prospective observational study of the effect of critical illness on ultrastructural and microscopic morphology of duodenal mucosa. Critical Care and Resuscitation, 18(2), 102-108.
Scopus6 WoS6 Europe PMC52016 Dunn, L., Burt, A., Hayes, N., & Griffin, S. (2016). Columnar metaplasia in the esophageal remnant after esophagectomy: a common occurrence and a valuable insight into the development of Barrett esophagus. Annals of Surgery, 264(6), 1016-1021.
Scopus14 WoS9 Europe PMC82016 Burt, A., & Whelan, E. (2016). Professor Sir Roddy MacSween - Obituary. HISTOPATHOLOGY, 68(6), 773-775.
2016 Shay, J. W., Homma, N., Zhou, R., Naseer, M. I., Chaudhary, A. G., Al-Qahtani, M., . . . Alqahtani, M. H. (2016). Abstracts from the 3rd International Genomic Medicine Conference (3rd IGMC 2015) : Jeddah, Kingdom of Saudi Arabia. 30 November - 3 December 2015.. BMC genomics, 17 Suppl 6(Suppl 6), 487.
Europe PMC122016 Burt, A. D. (2016). From This Month's Histopathology. Histopathology, 68(4), 473-474.
2016 Shi, Z., Chen, W., Taylor, A., & Burt, A. (2016). Elevated transaminase levels among overweight adolescents in eastern China. Acta Paediatrica, International Journal of Paediatrics, 105(12), e593-e599.
2015 McPherson, S., Hardy, T., Henderson, E., Burt, A., Day, C., & Anstee, Q. (2015). Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management. Journal of Hepatology, 62(5), 1148-1155.
Scopus834 WoS689 Europe PMC5032015 Burt, A., Lackner, C., & Tiniakos, D. (2015). Diagnosis and assessment of NAFLD: definitions and histopathological classification. Seminars in Liver Disease, 35(3), 207-220.
Scopus110 WoS83 Europe PMC622015 Cornell, L., Munck, J., Alsinet, C., Villanueva, A., Ogle, L., Willoughby, C., . . . Reeves, H. (2015). DNA-PK—A Candidate Driver of Hepatocarcinogenesis and Tissue Biomarker That Predicts Response to Treatment and Survival. Clinical Cancer Research, 21(4), 925-933.
Scopus72 WoS68 Europe PMC552015 Bedossa, P., Burt, A. D., Brunt, E., Callea, F., Clouston, A. D., Dienes, H. P., . . . Wanless, I. R. (2015). Well-differentiated hepatocellular neoplasm of uncertain malignant potential - Reply. Human Pathology, 46(4), 635-636.
Scopus5 WoS5 Europe PMC42014 Bedossa, P., & FLIP Pathology Consortium. (2014). Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease. Hepatology, 60(2), 565-575.
Scopus508 WoS407 Europe PMC2552014 Probert, P., Ebrahimkhani, M., Oakley, F., Mann, J., Burt, A., Mann, D., & Wright, M. (2014). A reversible model for periportal fibrosis and a refined alternative to bile duct ligation. Toxicology Research, 3(2), 98-109.
Scopus11 WoS102014 McPherson, S., Henderson, E., Burt, A., Day, C., & Anstee, Q. (2014). Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease. Journal of Hepatology, 60(5), 1055-1062.
Scopus83 WoS67 Europe PMC542014 Brunt, E., Gouw, A., Hubscher, S., Tiniakos, D., Bedossa, P., Burt, A., . . . Wanless, I. (2014). Pathology of the liver sinusoids. Histopathology, 64(7), 907-920.
Scopus65 WoS46 Europe PMC392014 Liu, Y., Reeves, H., Burt, A., Tiniakos, D., McPherson, S., Leathart, J., . . . Anstee, Q. (2014). TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease. Nature Communications, 5(1), 4309-1-4309-6.
Scopus501 WoS371 Europe PMC3242014 Liu, Y., Patman, G., Leathart, J., Piguet, A., Burt, A., Dufour, J., . . . Anstee, Q. (2014). Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma. Journal of Hepatology, 61(1), 75-81.
Scopus447 WoS359 Europe PMC2722014 Masson, S., Emmerson, I., Henderson, E., Fletcher, E., Burt, A., Day, C., & Stewart, S. (2014). Clinical but not histological factors predict long-term prognosis in patients with histologically advanced non-decompensated alcoholic liver disease. Liver International, 34(2), 235-242.
Scopus37 WoS21 Europe PMC152013 Elsharkawy, A., Schwab, U., McCarron, B., Burt, A., Daly, A., Hudson, M., & Masson, S. (2013). Efavirenz induced acute liver failure requiring liver transplantation in a slow drug metaboliser. Journal of Clinical Virology, 58(1), 331-333.
Scopus16 WoS11 Europe PMC92013 Thompson, E., Burt, A., Barker, C., Kirby, J., & Brain, J. (2013). Development of a robust protocol for gene expression analysis using formalin-fixed, paraffin-embedded liver transplant biopsy specimens. Journal of Clinical Pathology, 66(9), 815-818.
Scopus2 WoS3 Europe PMC22013 Brain, J., Robertson, H., Thompson, E., Humphreys, E., Gardner, A., Booth, T., . . . Kirby, J. (2013). Biliary epithelial senescence and plasticity in acute cellular rejection. American Journal of Transplantation, 13(7), 1688-1702.
Scopus31 WoS23 Europe PMC152013 Bedossa, P., Burt, A., Brunt, E., Callea, F., Clouston, A., Dienes, H., . . . Wanless, I. (2013). Well-differentiated hepatocellular neoplasm of uncertain malignant potential: proposal for a new diagnostic category. Human Pathology, 45(3), 658-659.
Scopus47 WoS48 Europe PMC282013 Robinson, S., Mann, J., Vasilaki, A., Mathers, J., Burt, A., Oakley, F., . . . Mann, D. (2013). Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy model. Journal of Hepatology, 59(2), 318-326.
Scopus106 WoS81 Europe PMC632013 McPherson, S., Anstee, Q., Henderson, E., Day, C., & Burt, A. (2013). Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?. European Journal of Gastroenterology & Hepatology, 25(6), 652-658.
Scopus75 WoS67 Europe PMC412013 Hardy, T., Wells, C., Kendrick, S., Hudson, M., Day, C., Burt, A., . . . Stewart, S. (2013). White cell count and platelet count associate with histological alcoholic hepatitis in jaundiced harmful drinkers. BMC Gastroenterology, 13(1), 55-1-55-5.
Scopus35 WoS27 Europe PMC212013 Fairhall, E., Wallace, K., White, S., Huang, G., Shaw, J., Wright, S., . . . Wright, M. (2013). Adult human exocrine pancreas differentiation to hepatocytes - potential source of a human hepatocyte progenitor for use in toxicology research. Toxicology Research, 2(1), 80-87.
Scopus10 WoS102013 Moles, A., Sanchez, A., Banks, P., Murphy, L., Luli, S., Borthwick, L., . . . Oakley, F. (2013). Inhibition of RelA-Ser536 phosphorylation by a competing peptide reduces mouse liver fibrosis without blocking the innate immune response. Hepatology, 57(2), 817-828.
Scopus35 WoS27 Europe PMC212013 Lastowska, M., Al-Afghani, H., Al-Balool, H., Sheth, H., Mercer, E., Coxhead, J., . . . Jackson, M. (2013). Identification of a neuronal transcription factor network involved in medulloblastoma development. Acta neuropathologica communications, 1(1), 35-1-35-16.
Scopus40 WoS38 Europe PMC322013 Burt, A. (2013). Roger Cotton Histopathology Prize 2012. Histopathology, 62(7), 975.
2012 Elsharkawy, A., McPherson, S., Masson, S., Burt, A., Dawson, R., & Hudson, M. (2012). Cholestase bei jungen Mannern nach Anabolika-Einnahme [Cholestasis secondary to anabolic steroid use in young men]. Praxis, 101(10), 661-664.
2012 Burt, A. D. (2012). Editorial. Histopathology, 60(6), 853.
2012 Burt, A. (2012). Roger Cotton Histopathology prize 2011. Histopathology, 61(5), 759.
2012 Mathurin, P., Hadengue, A., Bataller, R., Addolorato, G., Burra, P., Burt, A., . . . Nevens, F. (2012). EASL clinical practical guidelines: management of alcoholic liver disease. Journal of Hepatology, 57(2), 399-420.
Scopus605 WoS487 Europe PMC3452012 Burt, A. D. (2012). Changing of the guard. Histopathology, 60(2), 233-235.
Scopus2 WoS2 Europe PMC22012 Simeon-Dubach, D., Burt, A. D., & Hall, P. A. (2012). Quality really matters: The need to improve specimen quality in biomedical research. Journal of Pathology, 228(4), 431-433.
Scopus44 WoS36 Europe PMC272012 Zeybel, M., Hardy, T., Wong, Y. K., Mathers, J. C., Fox, C. R., Gackowska, A., . . . Mann, J. (2012). Erratum: Multigenerational epigenetic adaptation of the hepatic woundhealing response (Nature Medicine (2012) 18 (1369-1377)). Nature Medicine, 18(10), 1592.
Scopus6 WoS52012 Tunwar, S., Trembling, P., Guha, I., Parkes, J., Kaye, P., Burt, A., . . . Rosenberg, W. (2012). Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease. Hepatology, 57(1), 103-111.
Scopus100 WoS84 Europe PMC582012 Robinson, S., Wilson, C., Burt, A., Manas, D., & White, S. (2012). Chemotherapy-associated liver injury in patients with colorectal liver metastases: a systematic review and meta-analysis. Annals of Surgical Oncology, 19(13), 4287-4299.
Scopus176 WoS146 Europe PMC1032012 Zeybel, M., Hardy, T., Wong, Y., Mathers, J., Fox, C., Gackowska, A., . . . Mann, J. (2012). Multigenerational epigenetic adaptation of the hepatic wound-healing response. Nature Medicine, 18(9), 1369-1377.
Scopus238 WoS202 Europe PMC1692012 Bechmann, L., Gastaldelli, A., Vetter, D., Patman, G., Pascoe, L., Hannivoort, R., . . . Reeves, H. (2012). Glucokinase links Kruppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease. Hepatology, 55(4), 1083-1093.
Scopus56 WoS51 Europe PMC392012 Simeon-Dubach, D., Burt, A. D., & Hall, P. A. (2012). Quality really matters: the need to improve specimen quality in biomedical research. Histopathology, 61(6), 1003-1005.
Scopus15 WoS12 Europe PMC92012 Perugorria, M., Wilson, C., Zeybel, M., Walsh, M., Amin, S., Robinson, S., . . . Mann, J. (2012). Histone methyltransferase ASH1 orchestrates fibrogenic gene transcription during myofibroblast transdifferentiation. Hepatology, 56(3), 1129-1139.
Scopus116 WoS98 Europe PMC812012 Kelly, P. J., Spence, R., Dasari, B. V., Burt, A. D., Taylor, M., & Loughrey, M. B. (2012). Primary hepatocellular carcinoma of the pancreas: a case report and review of the heterogeneous group of pancreatic hepatoid carcinomas. Histopathology, 60(6), 1012-1015.
Scopus20 WoS18 Europe PMC192012 Elsharkawy, A. M., McPherson, S., Masson, S., Burt, A. D., Dawson, R. T., & Hudson, M. (2012). Cholestasis secondary to anabolic steroid use in young men. BMJ, 344(7843), e468-1-e468-3.
Scopus31 WoS18 Europe PMC142011 de Alwis, N., Aithal, G., Bugianesi, E., Leathart, J., Hudson, G., Pyle, A., . . . Day, C. P. (2011). Mitochondrial DNA does not contribute to the heritability of non-alcoholic fatty liver disease. Mitochondrion, 11(1), 234-235.
Scopus4 WoS4 Europe PMC22011 Ebrahimkhani, M., Oakley, F., Murphy, L., Mann, J., Moles, A., Perugorria, M., . . . Mann, D. (2011). Stimulating healthy tissue regeneration by targeting the 5-HT₂B receptor in chronic liver disease. Nature Medicine, 17(12), 1668-1673.
Scopus177 WoS150 Europe PMC1182011 Chan, A., & Burt, A. (2011). Liver cell dysplasia and early hepatocellular carcinoma. Diagnostic Histopathology, 17(12), 512-520.
Scopus12011 Griffin, S., Burt, A., & Jennings, N. (2011). Lymph node metastasis in early esophageal adenocarcinoma. Annals of Surgery, 254(5), 731-737.
Scopus57 WoS46 Europe PMC282010 Van Der Laan, L., Hudson, M., McPherson, S., Zondervan, P., Thomas, R., Kwekkeboom, J., . . . Metselaar, H. (2010). Results of a two-center study comparing hepatic fibrosis progression in HCV-positive liver transplant patients receiving cyclosporine or tacrolimus. Transplantation Proceedings, 42(10), 4573-4577.
Scopus8 WoS9 Europe PMC82010 Rygiel, K., Robertson, H., Willet, J., Brain, J., Burt, A., Jones, D., & Kirby, J. (2010). T Cell-mediated biliary epithelial-to-mesenchymal transition in liver allograft rejection. Liver Transplantation, 16(5), 567-576.
Scopus14 WoS10 Europe PMC72010 McPherson, S., Stewart, S., Henderson, E., Burt, A., & Day, C. (2010). Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut, 59(9), 1265-1269.
Scopus709 WoS591 Europe PMC4582010 Harte, A., da Silva, N., Creely, S., McGee, K., Billyard, T., Youssef-Elabd, E., . . . McTernan, P. (2010). Elevated endotoxin levels in non-alcoholic fatty liver disease. Journal of Inflammation, 7(15), 1-10.
Scopus315 WoS269 Europe PMC2162010 Parkes, J., Roderick, P., Harris, S., Day, C., Mutimer, D., Collier, J., . . . Rosenberg, W. (2010). Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease. Gut, 59(9), 1245-1251.
Scopus280 WoS242 Europe PMC1812010 Dongiovanni, P., Valenti, L., Rametta, R., Daly, A., Nobili, V., Mozzi, E., . . . Fargion, S. (2010). Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease. Gut, 59(2), 267-273.
Scopus147 WoS113 Europe PMC942010 Brain, J. G., & Burt, A. D. (2010). Abrikosoff's tumor and the hepatobiliary system: A curiosa revisited. Gastroenterology and Hepatology, 6(5), 337-338. 2010 Wallace, K., Flecknell, P., Burt, A., & Wright, M. (2010). Disrupted pancreatic exocrine differentiation and malabsorption in response to chronic elevated systemic glucocorticoid. American Journal of Pathology, 177(3), 1225-1232.
Scopus20 WoS17 Europe PMC92010 Gieling, R., Elsharkawy, A., Caamano, J., Cowie, D., Wright, M., Ebrahimkhani, M., . . . Mann, D. (2010). The c-Rel subunit of nuclear factor-κB regulates murine liver inflammation, wound-healing, and hepatocyte proliferation. Hepatology, 51(3), 922-931.
Scopus52 WoS48 Europe PMC382009 De Alwis, N., Hudson, G., Burt, A., Day, C., & Chinnery, P. (2009). Human liver stem cells originate from the canals of hering. Hepatology, 50(3), 992-993.
Scopus16 WoS14 Europe PMC142009 Burt, A. (2009). Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology, 49(2), 658-664.
Scopus689 WoS553 Europe PMC4062009 Frith, J., Day, C., Henderson, E., Burt, A., & Newton, J. (2009). Non-alcoholic fatty liver disease in older people. Gerontology, 55(6), 607-613.
Scopus190 WoS145 Europe PMC1172008 Duconge, J., Merino, N., Alvarez, D., Beausoleil, I., Fernandez-Sanchez, E., Rodriguez, L., & Burt, A. (2008). Kinetics of monoclonal anti-epidermal growth factor receptor antibody (IOR EGF/R3)-induced apoptosis in human carcinoma bearing nude mice. Puerto Rico Health Sciences Journal, 27(1), 35-41. 2008 Gennery, A., Slatter, M., Rice, J., Hoefsloot, L., Barge, D., McLean-Tooke, A., . . . Johnson, D. (2008). Mutations in CHD7 in patients with CHARGE syndrome cause T-B + natural killer cell + severe combined immune deficiency and may cause Omenn-like syndrome. Clinical and Experimental Immunology, 153(1), 75-80.
Scopus97 WoS78 Europe PMC652008 Rygiel, K., Robertson, H., Marshall, H., Pekalski, M., Zhao, L., Booth, T., . . . Kirby, J. (2008). Epithelial-mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease. Laboratory Investigation, 88(2), 112-123.
Scopus220 WoS191 Europe PMC1552008 Wallace, K., Burt, A., & Wright, M. (2008). Liver fibrosis. Biochemical Journal, 411(1), 1-18.
Scopus291 WoS361 Europe PMC1792008 Guha, I., Parkes, J., Roderick, P., Chattopadhyay, D., Cross, R., Harris, S., . . . Rosenberg, W. (2008). Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European liver fibrosis panel and exploring simple markers. Hepatology, 47(2), 455-460.
Scopus648 WoS535 Europe PMC3962008 Gieling, R., Burt, A., & Mann, D. (2008). Fibrosis and cirrhosis reversibility - molecular mechanisms. Clinics in Liver Disease, 12(4), 915-937.
Scopus82 WoS65 Europe PMC502008 Newton, J., Jones, D., Henderson, E., Kane, L., Wilton, K., Burt, A., & Day, C. (2008). Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease. Gut, 57(6), 807-813.
Scopus173 WoS142 Europe PMC1022008 Tiniakos, D., Mathew, J., Kittas, C., & Burt, A. (2008). Ontogeny of human intrahepatic innervation. Virchows Archiv-An International Journal of Pathology, 452(4), 435-442.
Scopus13 WoS10 Europe PMC102008 Jones, D. F. J., Palmer, J. M., Burt, A. D., & Kirby, J. A. (2008). The specificity of liver inflammation in mouse models of primary biliary cirrhosis. Hepatology, 48(4), 1353-1354.
Scopus1 Europe PMC12008 Kirby, J. A., Robertson, H., Marshall, H. L., Rygiel, K. A., Hudson, M., Jones, D. E. J., & Burt, A. D. (2008). Epithelial to mesenchymal transition in primary sclerosing cholangitis. Liver International, 28(8), 1176-1177.
Scopus6 WoS5 Europe PMC32008 Hedge, M. M., Thompson, N. P., Burt, A. D., Day, C. P., & Reeves, H. (2008). Warfarin induced cholestatic jaundice in a patient receiving total parenteral nutrition. CME Gastroenterology, Hepatology & Nutrition, 9(1), 27-29. 2007 Haugk, B., El-Refaie, A., & Burt, A. D. (2007). Pathology of liver transplantation. Current Diagnostic Pathology, 13(1), 75-84.
Scopus32007 Wilson, C. H., Agarwal, K., Carter, V., Burt, A. D., Hubscher, S., Talbot, D., . . . Manas, D. M. (2007). Late humoral rejection in a compliant ABO-compatible liver transplant recipient (vol 82, pg 988, 2006). TRANSPLANTATION, 83(1), 70. 2007 Prabhu, V. R., & Burt, A. D. (2007). Pathology of liver tumours. Surgery, 25(1), 10-15.
Scopus42007 Angulo, P., Hui, J. M., Marchesini, G., Bugianesi, E., George, J., Farrell, G. C., . . . Day, C. P. (2007). The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology, 45(4), 846-854.
Scopus2450 WoS2024 Europe PMC15272007 Robertson, H., Kirby, J. A., Yip, W. W., Jones, D. E. J., & Burt, A. D. (2007). Biliary epithelial-mesenchymal transition in posttransplantation recurrence of primary biliary cirrhosis. Hepatology, 45(4), 977-981.
Scopus147 WoS121 Europe PMC1022007 Zhao, L., & Burt, A. D. (2007). The diffuse stellate cell system. Journal of Molecular Histology, 38(1), 53-64.
Scopus74 WoS59 Europe PMC462007 Wilson, C. H., Agarwal, K., Carter, V., Burt, A. D., Hübscher, S., Talbot, D., . . . Manas, D. M. (2007). Erratum: Late humoral rejection in a compliant ABO-compatible liver transplant recipient (Transplantation (2006) 82, (988)). Transplantation, 83(1), 70.
2006 Wilson, C. H., Agarwal, K., Talbot, D., Jaques, B. C., Manas, D. M., Carter, V., . . . Hübscher, S. (2006). Late humoral rejection in a compliant ABO-compatible liver transplant recipient [4]. Transplantation, 82(7), 988-989.
Scopus36 WoS34 Europe PMC242006 Benitez-Rajal, J., Lorite, M. J., Burt, A. D., Day, C. P., & Thompson, M. G. (2006). Phospholipase D and extracellular signal-regulated kinase in hepatic stellate cells: Effects of platelet-derived growth factor and extracellular nucleotides. American Journal of Physiology - Gastrointestinal and Liver Physiology, 291(5), G977-G986.
Scopus11 WoS12 Europe PMC82006 Mathew, J., Igbokwe, U. O., Morley, N., & Burt, A. D. (2006). Tempting liver fibrosis? Long-term psoriatic methotrexate therapy and heterozygous α <inf>1</inf>-antitrypsin deficiency. Dermatology, 213(2), 147-149.
2006 Tyler, J. R., Robertson, H., Booth, T. A., Burt, A. D., & Kirby, J. A. (2006). Chronic allograft nephropathy: Intraepithelial signals generated by transforming growth factor-β and bone morphogenetic protein-7. American Journal of Transplantation, 6(6), 1367-1376.
Scopus38 WoS37 Europe PMC282006 Nielsen, S. U., Bassendine, M. F., Burt, A. D., Martin, C., Pumeechockchai, W., & Toms, G. L. (2006). Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients. Journal of Virology, 80(5), 2418-2428.
Scopus300 WoS278 Europe PMC2222006 Price, D. A., Bassendine, M. F., Norris, S. M., Golding, C., Toms, G. L., Schmid, M. L., . . . Donaldson, P. T. (2006). Apolipoprotein ε3 allele is associated with persistent hepatitis C virus infection. Gut, 55(5), 715-718.
Scopus82 WoS72 Europe PMC602006 Yip, W. W., & Burt, A. D. (2006). Alcoholic liver disease. Seminars in Diagnostic Pathology, 23(3-4), 149-160.
Scopus149 WoS114 Europe PMC712006 Fenwick, F., Bassendine, M. F., Agarwal, K., Bevitt, D., Pumeechockchai, W., Burt, A. D., & Toms, G. L. (2006). Immunohistochemical assessment of hepatitis C virus antigen in cholestatic hepatitis after liver transplantation. Journal of Clinical Pathology, 59(2), 174-178.
Scopus17 WoS13 Europe PMC112005 Ahmed El-Refaie, A. M., & Burt, A. D. (2005). Mast cells and c-Kit expression in liver allograft rejection. Histopathology, 47(4), 375-381.
Scopus21 WoS14 Europe PMC82005 Albano, E., Mottaran, E., Vidali, M., Reale, E., Saksena, S., Occhino, G., . . . Day, C. P. (2005). Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis. Gut, 54(7), 987-993.
Scopus194 WoS172 Europe PMC1262005 Lamb, P. J., Griffin, S. M., Burt, A. D., Lloyd, J., Karat, D., & Hayes, N. (2005). Sentinel node biopsy to evaluate the metastatic dissemination of oesophageal adenocarcinoma. British Journal of Surgery, 92(1), 60-67.
Scopus70 WoS60 Europe PMC552005 Mathew, J., Leong, M. Y., Morley, N., & Burt, A. D. (2005). A liver fibrosis cocktail? Psoriasis, methotrexate and genetic hemochromatosis. BMC Dermatology, 5(1), 6 pages.
Scopus3 WoS2 Europe PMC22005 Rai, R., Richardson, C., Flecknell, P., Robertson, H., Burt, A., & Manas, D. M. (2005). Study of apoptosis and heat shock protein (HSP) expression in hepatocytes following radiofrequency ablation (RFA). Journal of Surgical Research, 129(1), 147-151.
Scopus84 Europe PMC482005 Rostron, A., Carter, V., Mutunga, M., Cavanagh, G., O'Suilleabhain, C., Burt, A., . . . Manas, D. (2005). A case of acute humoral rejection in liver transplantation: Successful treatment with plasmapheresis and mycophenolate mofetil. Transplant International, 18(11), 1298-1301.
Scopus30 WoS28 Europe PMC212004 Rosenberg, W. M. C., Voelker, M., Thiel, R., Becka, M., Burt, A., Schuppan, D., . . . Arthur, M. J. P. (2004). Serum markers detect the presence of liver fibrosis: A cohort study. Gastroenterology, 127(6), 1704-1713.
Scopus957 WoS775 Europe PMC5912004 Palmer, J. M., Robe, A. J., Burt, A. D., Kirby, J. A., & Jones, D. E. J. (2004). Covalent modification as a mechanism for the breakdown of immune tolerance to pyruvate dehydrogenase complex in the mouse. Hepatology, 39(6), 1583-1592.
Scopus24 WoS23 Europe PMC162004 Nielsen, S. U., Bassendine, M. F., Burt, A. D., Bevitt, D. J., & Toms, G. L. (2004). Characterization of the genome and structural proteins of hepatitis C virus resolved from infected human liver. Journal of General Virology, 85(6), 1497-1507.
Scopus55 WoS58 Europe PMC412004 Aithal, G. P., Haugk, B., Das, S., Card, T., Burt, A. D., & Record, C. O. (2004). Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: Are serial liver biopsies justified?. Alimentary Pharmacology and Therapeutics, 19(4), 391-399.
Scopus127 WoS94 Europe PMC622004 Robertson, H., Ali, S., McDonnell, B. J., Burt, A. D., & Kirby, J. A. (2004). Chronic Renal Allograft Dysfunction: The Role of T Cell-Mediated Tubular Epithelial to Mesenchymal Cell Transition. Journal of the American Society of Nephrology, 15(2), 390-397.
Scopus108 WoS96 Europe PMC872003 Roskams, T., Baptista, A., Bianchi, L., Burt, A., Callea, F., Denk, H., . . . Thaler, H. (2003). Histopathology of portal hypertension: A practical guideline. Histopathology, 42(1), 2-13.
Scopus58 WoS40 Europe PMC292002 Jones, D. E. J., Palmer, J. M., Burt, A. D., Walker, C., Robe, A. J., & Kirby, J. A. (2002). Bacterial motif DNA as an adjuvant for the breakdown of immune self-tolerance to pyruvate dehydrogenase complex. Hepatology, 36(3), 679-686.
Scopus45 WoS40 Europe PMC342002 Burt, A. D. (2002). Primary biliary cirrhosis and other ductopenic diseases. Clinics in Liver Disease, 6(2), 363-380.
Scopus26 Europe PMC112002 Agarwal, K., Jones, D. E. J., Watt, F. E., Burt, A. D., Floreani, A., & Bassendine, M. F. (2002). Familial primary biliary cirrhosis and autoimmune cholangitis. Digestive and Liver Disease, 34(1), 50-52.
Scopus5 WoS4 Europe PMC22002 Agarwal, K., Jones, D. E. J., Burt, A. D., Hudson, M., & James, O. F. W. (2002). Metastatic breast carcinoma presenting as acute liver failure and portal hypertension. American Journal of Gastroenterology, 97(3), 750-751.
Scopus19 WoS12 Europe PMC122002 Jones, D. E. J., Palmer, J. M., Bennett, K., Robe, A. J., Yeaman, S. J., Robertson, H., . . . Kirby, J. A. (2002). Investigation of a mechanism for accelerated breakdown of immune tolerance to the primary biliary cirrhosis-associated autoantigen, pyruvate dehydrogenase complex. Laboratory Investigation, 82(2), 211-219.
Scopus25 WoS24 Europe PMC192002 Prince, M. I., Burt, A. D., & Jones, D. E. J. (2002). Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis. Gut, 50(3), 436-439.
Scopus179 WoS141 Europe PMC992002 Lamb, P. J., Dresner, S. M., Lloyd, J., O'Driscoll, K., Burt, A. D., Karat, D., . . . Griffin, S. M. (2002). The sentinel node concept in the metastatic dissemination of oesophageal adenocarcinoma. BRITISH JOURNAL OF SURGERY, 89, 37. 2001 Burt, A. D. (2001). Steatosis and steatohepatitis. Current Diagnostic Pathology, 7(2), 141-147.
Scopus102001 Benitez, J., Lorite, M. J., Burt, A. D., Day, C. P., & Geerts, A. (2001). Identification of phospholipase D gene products in activated rat hepatic stellate cells - Stimulation by PDGF and nucleotides. JOURNAL OF HEPATOLOGY, 34, 90. 2001 Reeves, H. L., Burt, A. D., & Day, C. P. (2001). Integrin receptor expression changes in diseased hepatic stellate cells. GUT, 48, A108-A109. 2001 Aithal, G. P., Haugk, B., Gumustop, B., Burt, A. D., & Record, C. O. (2001). Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: Are serial liver biopsies justified?.. HEPATOLOGY, 34(4), 342A. 2001 Mohamed, M. A. S., Burt, A. D., Robertson, H., Kirby, J. A., & Talbot, D. (2001). TGF-β expression in protocol transplant liver biopsies:: A comparative study between cyclosporine-A (CyA) and tacrolimus (FK 506) immunosuppression. TRANSPLANTATION PROCEEDINGS, 33(1-2), 1378-1380.
WoS5 Europe PMC62001 Robertson, H., Wong, W. K., Burt, A. D., Mohamed, M. A. S., Talbot, D., & Kirby, J. A. (2001). Relationship between TGFβ<sub>1</sub>, intratubular CD103 positive T cells and acute renal allograft rejection. TRANSPLANTATION PROCEEDINGS, 33(1-2), 1159.
WoS6 Europe PMC52001 Jowett, S. L., Agarwal, K., Smith, B. C., Craig, W., Hewett, M., Bassendine, D. R., . . . Bassendine, M. F. (2001). Managing chronic hepatitis C acquired through intravenous drug use. QJM: An International Journal of Medicine, 94(3), 153-158.
Scopus57 WoS45 Europe PMC312001 Robertson, H., Keong Wong, W., Talbot, D., Burt, A. D., & Kirby, J. A. (2001). Tubulitis after renal transplantation: Demonstration of an association between CD103+ T cells, transforming growth factor β<inf>1</inf> expression and rejection grade. Transplantation, 71(2), 306-313.
Scopus62 WoS54 Europe PMC432001 Koeppen, H. K. W., Wright, B. D., Burt, A. D., Quirke, P., McNicol, A. M., Dybdal, N. O., . . . Hillan, K. J. (2001). Overexpression of HER2/neu in solid tumours: An immunohistochemical survey. Histopathology, 38(2), 96-104.
Scopus148 WoS130 Europe PMC952001 Burt, A. D. (2001). Autoimmune liver disease. CPD Bulletin Cellular Pathology, 3(2), 64-67. 2001 Drasar, P. (2001). Editorial. CHEMICKE LISTY, 95(4), 193.
2000 Reynaert, H., Burt, A., & Geerts, A. (2000). Prions in activated hepatic stellate cells: Not a surprise after all. Journal of Hepatology, 33(5), 838-841.
Scopus4 WoS4 Europe PMC32000 Jones, D. E. J., Palmer, J. M., Kirby, J. A., De Cruz, D. J., McCaughan, G. W., Sedgwick, J. D., . . . Bassendine, M. F. (2000). Experimental autoimmune cholangitis: A mouse model of immune-mediated cholangiopathy. Liver, 20(5), 351-356.
Scopus33 WoS29 Europe PMC202000 Reeves, H. L., Dack, C. L., Peak, M., Burt, A. D., & Day, C. P. (2000). Stress-activated protein kinases in the activation of rat hepatic stellate cells in culture. Journal of Hepatology, 32(3), 465-472.
Scopus65 WoS59 Europe PMC432000 Newton, J. L., Jones, D. E., Metcalf, J. V., Park, J. B., Burt, A. D., Bassendine, M. F., & James, O. F. W. (2000). Presentation and mortality of primary biliary cirrhosis in older patients. Age and Ageing, 29(4), 305-309.
Scopus27 WoS16 Europe PMC162000 Reeves, H. L., Thompson, M. G., Dack, C. L., Burt, A. D., & Day, C. P. (2000). The role of phosphatidic acid in platelet-derived growth factor-induced proliferation of rat hepatic stellate cells. Hepatology, 31(1), 95-100.
Scopus29 WoS26 Europe PMC172000 Bennett, K. M., Robertson, H., Bone, M., Burt, A. D., Kirby, J. A., & Jones, D. E. (2000). Immunohistochemical analaysis of portal tract changes in experimental autoimmune cholangitis, a murine model of non-suppurative destructive cholangitis (NSDC).. HEPATOLOGY, 32(4), 171A. 2000 Allen, M. (2000). Editorial. Outskirts, 7(4), 270.
2000 Eza, D., Burr, A. W., O'Toole, K., & Burt, A. D. (2000). Inhibition of non-parenchymal cell responses to acute liver injury using neutralising anti-growth factor antibodies. JOURNAL OF PATHOLOGY, 190, 12A. 2000 Lorite, M. J., Benitez, J., Burt, A. D., Day, C. P., & Thompson, M. G. (2000). Nucleotides stimulate protein synthesis in hepatic stellate cells: Potential role of phospholipase D - Mediated lipid hydrolysis.. JOURNAL OF PATHOLOGY, 190, 4A. 2000 Burt, A. D., Jones, D. E. J., Palmer, J. M., Kirby, J. A., DeCruz, D. J., McCaughan, G. W., . . . Bassendine, M. F. (2000). Histopathology of experimental autoimmune cholangitis - a mouse model of primary biliary cirrhosis. JOURNAL OF PATHOLOGY, 190, 3A. 2000 Burt, A. D. (2000). Viral hepatitis in Western Europe. JOURNAL OF PATHOLOGY, 190, 28A. 2000 Bone, M. H., Jones, D. E., Kirby, J. A., Robertson, H., Burt, A. D., Jawahari, A., & Hudson, M. (2000). Ulcerative colitis:: An investigation of the potential role played by a <SUP>E</SUP>B<sub>7</sub> +VE T-cells.. GASTROENTEROLOGY, 118(4), A1334.
1999 Fenwick, F., Bevitt, D., Burt, A. D., Pumeechockchai, W., Bassendine, M. F., & Toms, G. L. (1999). Detection of hepatitis C virus structural and nonstructural proteins by immunohistochemistry.. HEPATOLOGY, 30(4), 208A. 1999 Smith, B. C., Grove, J., Burt, A. D., & Bassendine, M. F. (1999). No evidence for involvement of interleukin-10 (IL-10) promoter gene polymorphisms in infuencing outcome of hepatitis C virus infection. HEPATOLOGY, 30(4), 590A. 1999 Reeves, H. L., Thompson, M. G., Burt, A. D., & Day, C. P. (1999). Signal cascade cross-talk in PDGF-induced HSC proliferation. GUT, 44, A97. 1999 Jones, D. E., Palmer, J. M., Yeaman, S. J., Kirby, J. A., Bassendine, M. F., & Burt, A. D. (1999). The time-course of bile duct lesion development in experimental autoimmune cholangitis (a mouse model of primary biliary cirrhosis-PBC).. HEPATOLOGY, 30(4), 564A. 1999 Case, M. C., Burt, A. D., Hughes, J., Palmer, J. M., Collier, J. D., Bassendine, M. F., . . . Major, G. N. (1999). Erratum: Enhanced ultrasensitive detection of structurally diverse antigens using a single immuno-PCR assay protocol (Journal of Immunological Methods (1999) 223 (93-106)). Journal of Immunological Methods, 226(1-2), 189-190.
1999 Jones, D. E., Palmer, J. M., Yeaman, S. J., Kirby, J. A., Bassendine, M. F., & Burt, A. D. (1999). The time-course of bile duct lesion development in experimental autoimmune cholangitis (A mouse model of primary biliary cirrhosis -PBC).. HEPATOLOGY, 30(4), 318A.
WoS21999 Case, M. C., Burt, A. D., Hughes, J., Palmer, J. M., Collier, J. D., Bassendine, M. F., . . . Major, G. N. (1999). Enhanced ultrasensitive detection of structurally diverse antigens using a single immuno-PCR assay protocol (vol 223, pg 93, 1999). JOURNAL OF IMMUNOLOGICAL METHODS, 226(1-2), 189-190. 1999 Wright, C., Strauss, S., Toole, K., Burt, A. D., & Robson, S. C. (1999). Composition of the pulmonary interstitium during normal development of the human fetus. Pediatric and Developmental Pathology, 2(5), 424-431.
Scopus18 WoS15 Europe PMC131999 Burt, A. D. (1999). Pathobiology of hepatic stellate cells. Journal of Gastroenterology, 34(3), 299-304.
Scopus46 WoS42 Europe PMC301999 James, O. E. W., Bhopal, R., Howel, D., Gray, J., Burt, A. D., & Metcalf, J. V. (1999). Primary biliary cirrhosis once rare, now common in the United Kingdom?. Hepatology, 30(2), 390-394.
Scopus212 WoS187 Europe PMC1401999 Jones, D. E. J., James, O. E. W., Portmann, B., Burt, A. D., Williams, R., & Hudson, M. (1999). Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis. Hepatology, 30(1), 53-57.
Scopus101 WoS77 Europe PMC531999 Case, M. C., Burt, A. D., Hughes, J., Palmer, J. M., Collier, J. D., Bassendine, M. F., . . . Major, G. N. (1999). Enhanced ultrasensitive detection of structurally diverse antigens using a single immuno-PCR assay protocol. Journal of Immunological Methods, 223(1), 93-106.
Scopus16 WoS12 Europe PMC71999 Lorite, M. J., Benitez, J., Bleazard, L., Burt, A. D., Day, C. P., & Thompson, M. G. (1999). Stimulation of protein and DNA synthesis by ATP in hepatic stellate cells: Potential role of phospholipase D-mediated lipid hydrolysis.. HEPATOLOGY, 30(4), 487A. 1998 Burr, A. W., Toole, K., Chapman, C., Hines, J. E., & Burt, A. D. (1998). Anti-hepatocyte growth factor antibody inhibits hepatocyte proliferation during liver regeneration. Journal of Pathology, 185(3), 298-302.
Scopus64 WoS54 Europe PMC381998 Green, S. E., Chapman, P., Burn, J., Burt, A. D., Bennett, M., Appleton, D. R., . . . Mathers, J. C. (1998). Colonic epithelial cell proliferation in hereditary non-polyposis colorectal cancer. Gut, 43(1), 85-92.
Scopus15 WoS16 Europe PMC221998 Olivieri, N. F., Brittenham, G. M., Mclaren, C. E., Templeton, D. M., Cameron, R. G., Mcclelland, R. A., . . . Fleming, K. A. (1998). Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major. New England Journal of Medicine, 339(7), 417-423.
Scopus369 WoS315 Europe PMC2021998 Smith, B. C., Grove, J., Guzail, M. A., Day, C. P., Daly, A. K., Burt, A. D., & Bassendine, M. F. (1998). Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology, 27(6), 1695-1699.
Scopus216 WoS190 Europe PMC1281998 Karayiannis, P., Brind, A. M., Pickering, J., Mathew, J., Burt, A. D., Hess, G., . . . Thomas, H. C. (1998). Hepatitis G virus does not cause significant liver disease after liver transplantation. Journal of Viral Hepatitis, 5(1), 35-42.
Scopus13 WoS8 Europe PMC61998 Johnson, S. J., Burr, A. W., Toole, K., Dack, C. L., Mathew, J., & Burt, A. D. (1998). Macrophage and hepatic stellate cell responses during experimental hepatocarcinogenesis. Journal of Gastroenterology and Hepatology (Australia), 13(2), 145-151.
Scopus17 WoS19 Europe PMC111998 Grove, J., Daly, A. K., Burt, A. D., Guzail, M., James, O. F. W., Bassendine, M. F., & Day, C. P. (1998). Heterozygotes for HFE mutations have no increased risk of advanced alcoholic liver disease. Gut, 43(2), 262-266.
Scopus90 WoS73 Europe PMC431998 Smith, B. C., Grove, J., Day, C. P., Daly, A. K., Burt, A. D., & Bassendine, M. F. (1998). Heterozygosity for haemochromatosis is associated with more fibrosis in chronic hepatitis C. GUT, 43(1), 154. 1998 Reeves, H. L., Peak, M., Burt, A. D., & Day, C. P. (1998). The antifibrogenic effect of interferon-α is via inhibition of p38 map kinase activity. GUT, 43(1), 152. 1998 Burt, A. D., Mutton, A., & Day, C. P. (1998). Diagnosis and interpretation of steatosis and steatohepatitis. Seminars in Diagnostic Pathology, 15(4), 246-258.
Scopus265 WoS215 Europe PMC1341998 Reeves, H. L., Peak, M., Burt, A. D., & Day, C. P. (1998). Stress-activated protein kinases (SAPKs) are involved in the activation of hepatic stellate cells. GUT, 43(1), 151. 1998 Thompson, M. G., Dack, C., Reeves, H. L., Burt, A. D., & Day, C. P. (1998). PDGF but not TGFα activates phospholipase C and phospholipase D mediated lipid hydrolysis in hepatic stellate cells.. HEPATOLOGY, 28(4), 299A.
WoS11998 Newton, J. L., Jones, D. E. J., Metcalf, J. V., Burt, A. D., Bassendine, M. F., & James, O. F. W. (1998). The presentation of Primary Biliary Cirrhosis in the elderly.. GASTROENTEROLOGY, 114(4), A1311.
WoS11998 Burt, A. D. (1998). Untitled. LIVER, 18(1), 1. 1998 Grove, J., Daly, A. K., Burt, A. D., Guzail, M., Bassendine, M. F., & Day, C. P. (1998). Do HLA-H mutations influence liver iron content or disease risk in alcoholics?. GUT, 43(1), 153-154. 1998 Newton, J. L., Jones, D. E. J., Metcalf, J. V., Burt, A. D., Bassendine, M. F., & James, O. F. W. (1998). Primary biliary cirrhosis in the elderly: Increased liver related mortality despite similar clinical features at presentation.. HEPATOLOGY, 28(4), 540A. 1997 Park, J. B., Hudson, M., Gray, S., & Burt, A. D. (1997). Abnormalities of portal tract vasculature in primary biliary cirrhosis. JOURNAL OF PATHOLOGY, 181, A49. 1997 Smith, B. C., Chapman, C. E., Burt, A. D., Toms, G. L., & Bassendine, M. F. (1997). Post-transfusion hepatitis C: Variable outcome in a cohort of donor-recipient pairs. GUT, 41, A129. 1997 Grove, J., Daly, A. K., Burt, A. D., Guzail, M., Bassendine, M. P., & Day, C. P. (1997). HLA-H mutations, hepatic iron content and risk of advanced liver disease in alcoholics.. HEPATOLOGY, 26(4), 585. 1997 Smith, B. C., Grove, J., Day, C. P., Daly, A. K., Burt, A. D., & Bassendine, M. F. (1997). Heterozygosity for haemochromatosis is associated with more fibrosis in chronic hepatitis C.. HEPATOLOGY, 26(4), 1899. 1997 Chapman, C., Mathew, J., Milton, I. D., Piggott, N., Steward, M., & Burt, A. D. (1997). Distribution of c-met protein in normal human liver and following acute and chronic liver injury. JOURNAL OF PATHOLOGY, 181, A10. 1997 Reeves, H. L., Peak, M., Burt, A. D., & Day, C. P. (1997). The role of stress-activated protein kinases in the activation of hepatic stellate cells.. HEPATOLOGY, 26(4), 1277.
WoS11997 Reeves, H. L., Peak, M., Burt, A. D., & Day, C. P. (1997). Interferon alpha inhibits p38 MAP kinase activity in hepatic stellate cells.. HEPATOLOGY, 26(4), 1276.
WoS11997 Newton, J. L., Burt, A. D., Park, J. B., Mathew, J., Bassendine, M. R., & James, O. F. W. (1997). Autoimmune hepatitis in older patients. Age and Ageing, 26(6), 441-444.
Scopus60 WoS44 Europe PMC281997 Smith, B. C., Chapman, C. E., Burt, A. D., Toms, G. L., & Bassendine, M. F. (1997). Outcome of post-transfusion hepatitis C: Disease severity in blood-component recipients and their implicated donors. QJM: An International Journal of Medicine, 90(9), 587-592.
Scopus12 WoS11 Europe PMC81997 Case, M., Major, G. N., Bassendine, M. F., & Burt, A. D. (1997). The universality of immuno-PCR for ultrasensitive antigen detection. BIOCHEMICAL SOCIETY TRANSACTIONS, 25(2), S374.
WoS13 Europe PMC61997 Wright, C., Burt, A. D., Strauss, S., Toole, K., & Robson, S. C. (1997). Cell proliferation in early human lung development.. JOURNAL OF PATHOLOGY, 182, A49. 1996 Brind, A. M., Watson, J. P., Burt, A., Kestevan, P., Wallis, J., Proctor, S. J., & Bassendine, M. F. (1996). Non-Hodgkin's lymphoma and hepatitis C virus infection. Leukemia and Lymphoma, 21(1-2), 127-130.
Scopus64 WoS65 Europe PMC401996 Ball, S. G., Davison, J. M., Burt, A. D., McNicol, A. M., & Baylis, P. H. (1996). Cushing's syndrome secondary to ectopic ACTH secretion from a primary ovarian carcinoma. Clinical Endocrinology, 45(6), 775-778.
Scopus13 WoS14 Europe PMC91996 Reeves, H. L., Burt, A. D., Wood, S., & Day, C. P. (1996). Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis. Journal of Hepatology, 25(5), 677-683.
Scopus136 WoS122 Europe PMC941996 Morris, A. A. M., Singh-Kler, R., Perry, R. H., Griffiths, P. D., Burt, A. D., Chee Pian Wong., . . . Turnbull, D. M. (1996). Respiratory chain dysfunction in progressive neuronal degeneration of childhood with liver disease. Journal of Child Neurology, 11(5), 417-419.
Scopus13 WoS11 Europe PMC51996 Burr, A. W., Toole, K., Mathew, J., Hines, J. E., Chapman, C., & Burt, A. D. (1996). Transforming growth factor-α expression is altered during experimental hepatocarcinogenesis. Journal of Pathology, 179(3), 276-282.
Scopus21 WoS21 Europe PMC141996 Hinchliffe, S. A., Woods, S., Gray, S., & Burt, A. D. (1996). Cellular distribution of androgen receptors in the liver. Journal of Clinical Pathology, 49(5), 418-420.
Scopus13 WoS11 Europe PMC71996 Watson, J. P., Brind, A. M., Chapman, C. E., Bates, C. L., Gould, F. K., Johnson, S. J., . . . Bassendine, M. F. (1996). Hepatitis C virus: Epidemiology and genotypes in the north east of England. Gut, 38(2), 269-276.
Scopus69 WoS59 Europe PMC431996 Leon, M. P., Bassendine, M. F., Gibbs, P., Burt, A. D., Thick, M., & Kirby, J. A. (1996). Hepatic allograft rejection: Regulation of the immunogenicity of human intrahepatic biliary epithelial cells. Liver Transplantation and Surgery, 2(1), 37-45.
Scopus11 Europe PMC61996 Mathew, J., Geerts, A., & Burt, A. D. (1996). Pathobiology of hepatic stellate cells. Hepato-Gastroenterology, 43(7), 72-91.
Scopus47 WoS35 Europe PMC271996 Burt, A. D. (1996). Special topic - Hepatic inflammation and fibrogenesis. Hepato-Gastroenterology, 43(7), 2-3. 1996 Goldin, R. D., Goldin, J. G., Burt, A. D., Dhillon, P. A., Hubscher, S., Wyatt, J., & Patel, N. (1996). Intra-observer and inter-observer variation in the histopathological assessment of chronic viral hepatitis. Journal of Hepatology, 25(5), 649-654.
Scopus148 WoS127 Europe PMC991996 Burr, A. W., Hillan, K. J., McLaughlin, K. E., Ferrier, R., Chapman, C., Mathew, J., & Burt, A. D. (1996). Hepatocyte growth factor levels in liver and serum increase during chemical hepatocarcinogenesis. Hepatology, 24(5), 1282-1287.
Scopus24 WoS22 Europe PMC81996 Newton, J. L., Burt, A. D., Park, J. B., Mathew, J., Bassendine, M. F., & James, O. F. W. (1996). Is the new international diagnostic scoring system for autoimmune hepatitis too rigid?. HEPATOLOGY, 24(4), 434. 1996 Case, M., Major, G. N., Bassendine, M. F., & Burt, A. D. (1996). The universality of immuno-PCR for ultrasensitive antigen detection. IMMUNOLOGY, 89, OH394. 1996 Mathew, J., Mines, J. E., Obafunwa, J. O., Burr, A. W., Toole, K., & Burt, A. D. (1996). CD44 is expressed in hepatocellular carcinomas showing vascular invasion. Journal of Pathology, 179(1), 74-79.
Scopus67 WoS45 Europe PMC371996 Tiniakos, D. G., Lee, J. A., & Burt, A. D. (1996). Innervation of the liver: Morphology and function. Liver, 16(3), 151-160.
Scopus60 WoS44 Europe PMC341996 Collier, J. D., Bassendine, M. F., Burt, A. D., & Major, G. N. (1996). Characterisation of the DNA repair enzyme for O<sup>6</sup>-methylguanine in cirrhosis. Journal of Hepatology, 25(2), 158-165.
Scopus16 WoS14 Europe PMC71996 Anderson, J. J., Birch, P. J., McIntosh, G. G., Parr, A., Burt, A. D., Lennard, T. W. J., . . . Angus, B. (1996). Over expression of CD44 variants acts as a useful secondary indicator of prognosis in patients with carcinomas of the breast. JOURNAL OF PATHOLOGY, 179, A19. 1996 Burt, A. D. (1996). Hepatic inflammation and fibrogenesis. HEPATO-GASTROENTEROLOGY, 43(7), 1. 1996 Reeves, H. L., Burt, A. D., & Day, C. P. (1996). The antiproliferative effect of IFN alpha correlates with inhibition of MAP kinase activation. HEPATOLOGY, 23(1), T53. 1995 BURR, A. W., TOOLE, K., HINES, J. E., CHAPMAN, C., & BURT, A. D. (1995). ANTI-HEPATOCYTE GROWTH-FACTOR ANTIBODY INHIBITS THE IN-VIVO PROLIFERATIVE RESPONSE OF HEPATOCYTES TO ACUTE LIVER-INJURY. GASTROENTEROLOGY, 108(4), A1041.
1995 Farrell, D. J., Hines, J. E., Walls, A. F., Kelly, P. J., Bennett, M. K., & Burt, A. D. (1995). Intrahepatic mast cells in chronic liver diseases. Hepatology, 22(4 PART 1), 1175-1181.
Scopus131 WoS111 Europe PMC761995 Johnson, S. J., Toole, K., Fraser, R., Rogers, G. W. T., Dobbs, B. R., & Burt, A. D. (1995). Methylprednisolone does not inhibit the nonparenchymal cell responses to dimethylnitrosamine-induced liver injury. International Hepatology Communications, 4(4), 201-206.
1995 Teli, M. R., James, O. F. W., Burt, A. D., Bennett, M. K., & Day, C. P. (1995). The natural history of nonalcoholic fatty liver: A follow-up study. Hepatology, 22(6), 1714-1719.
Scopus863 WoS733 Europe PMC5761995 Teli, M. R., Day, C. P., James, O. F. W., Burt, A. D., & Bennett, M. K. (1995). Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. The Lancet, 346(8981), 987-990.
Scopus445 WoS349 Europe PMC2521995 Leon, M. P., Kirby, J. A., Gibbs, P., Burt, A. D., & Bassendine, M. F. (1995). Immunogenicity of biliary epithelial cells: study of the expression of B7 molecules. Journal of Hepatology, 22(5), 591-595.
Scopus53 WoS49 Europe PMC271995 FARRELL, D. (1995). Intrahepatic mast cells in chronic liver diseases*1. Hepatology, 22(4), 1175-1181.
1995 Macey, A. C., Burke, F. D., Abbott, K., Barton, N. J., Bradbury, E., Bradley, A., . . . Woodbridge, S. (1995). Outcomes of hand surgery. Journal of Hand Surgery, 20(6), 841-855.
Scopus163 Europe PMC911995 REEVES, H. L., BURT, A. D., & DAY, C. P. (1995). MAPKINASE AND LIPID-DERIVED SIGNAL-TRANSDUCTION CASCADES IN HEPATIC STELLATE CELL-PROLIFERATION. HEPATOLOGY, 22(4), 693. 1995 M-H Ho, A., Contardi, L. A. H., Day, C. P., Burt, A. D., & James, O. F. W. (1995). Pure alcoholic fatty liver and progression to cirrhosis or fibrosis. The Lancet, 346(8989), 1562-1563.
Scopus5 WoS3 Europe PMC51995 TELI, M. (1995). The natural history of nonalcoholic fatty liver: A follow-up study. Hepatology, 22(6), 1714-1719.
1994 Johnson, S. J., Mathew, J., MacSween, R. N. M., Bennett, M. K., & Burt, A. D. (1994). Post-infantile giant cell hepatitis: Histological and immunohistochemical study. Journal of Clinical Pathology, 47(11), 1022-1027.
Scopus55 WoS40 Europe PMC351994 Mathew, J., Hines, J. E., James, O. F. W., & Burt, A. D. (1994). Non-parenchymal cell responses in paracetamol (acetaminophen)-induced liver injury. Journal of Hepatology, 20(4), 537-541.
Scopus32 WoS27 Europe PMC201994 TURNER, I. B., MYSZOR, M., MITCHISON, H. C., BENNETT, M. K., BURT, A. D., & JAMES, O. F. W. (1994). A two year controlled trial examining the effectiveness of ursodeoxycholic acid in primary biliary cirrhosis. Journal of Gastroenterology and Hepatology, 9(2), 162-168.
Scopus39 WoS41 Europe PMC301994 Collier, J. D., Carpenter, M., Burt, A. D., & Bassendine, M. F. (1994). Expression of mutant p53 protein in hepatocellular carcinoma. Gut, 35(1), 98-100.
Scopus23 WoS21 Europe PMC91994 MATHEW, J., HINES, J. E., TOOLE, K., JOHNSON, S. J., JAMES, O. F. W., & BURT, A. D. (1994). Quantitative analysis of macrophages and perisinusoidal cells in primary biliary cirrhosis. Histopathology, 25(1), 65-70.
Scopus34 WoS34 Europe PMC241994 TEILI, M. R., DAY, C. P., BURT, A. D., & JAMES, O. F. W. (1994). PATTERN OF STEATOSIS AND CONTINUED DRINKING PREDICT RISK OF PROGRESSION TO CIRRHOSIS IN PURE ALCOHOLIC FATTY LIVER. HEPATOLOGY, 20(4), A319.
WoS11994 BURR, A. W., TOOLE, K., MATHEW, J., HINES, J. E., CHAPMAN, C., & BURT, A. D. (1994). TRANSFORMING GROWTH-FACTOR-ALPHA AND EPIDERMAL GROWTH-FACTOR RECEPTOR IN EXPERIMENTAL HEPATOCARCINOGENESIS. HEPATOLOGY, 19(4), I46.
1994 REEVES, H. L., BURT, A. D., WOOD, S., JAMES, O. F. W., & DAY, C. P. (1994). LIPOCYTE ACTIVATION OCCURS IN THE ABSENCE OF HEPATITIS IN ALCOHOLIC LIVER-DISEASE AND CORRELATES WITH THE SEVERITY OF STEATOSIS. HEPATOLOGY, 20(4), A318.
WoS21994 COLLIER, J. D., MAJOR, G. N., BURT, A. D., & BASSENDINE, M. F. (1994). ANALYSIS OF DNA-REPAIR IN CIRRHOSIS OF DIFFERENT ETIOLOGIES. GUT, 35(5), A722. 1993 Burt, A. D., Le Bail, B., Balabaud, C., & Bioulac-Sage, P. (1993). Morphologic investigation of sinusoidal cells. Seminars in Liver Disease, 13(1), 21-38.
Scopus59 WoS40 Europe PMC211993 HINES, J. E., JOHNSON, S. J., & BURT, A. D. (1993). INVIVO RESPONSES OF MACROPHAGES AND PERISINUSOIDAL CELLS TO CHOLESTATIC LIVER-INJURY. AMERICAN JOURNAL OF PATHOLOGY, 142(2), 511-518.
WoS1411993 BURT, A. D., HUBSCHER, S. G., & HINES, J. E. (1993). PECAM-1 (CD31) IS EXPRESSED BY SINUSOIDAL ENDOTHELIAL-CELLS AND ACTIVATED ITO CELLS (LIPOCYTES) IN HUMAN LIVER. HEPATOLOGY, 18(4), A198.
1993 BURT, A. D., & MacSWEEN, R. N. M. (1993). Bile duct proliferation—its true significance?. Histopathology, 23(6), 599-602.
Scopus49 WoS44 Europe PMC301993 Day, C. P., Burt, A. D., Brown, A. S. M., Bennett, M. K., Farrell, D. J., James, O. F. W., & Yeaman, S. J. (1993). Plasma membrane form of phosphatidate phosphohydrolase: A possible role in signal transduction during liver fibrogenesis. Clinical Science, 85(3), 281-287.
Scopus6 WoS7 Europe PMC41993 Harrison, D. J., & Burt, A. D. (1993). Pathology of alcoholic liver disease. Bailliere's Clinical Gastroenterology, 7(3), 641-662.
Scopus12 WoS11 Europe PMC61993 Collier, J. D., Guo, K., Gullick, W. J., Bassendine, M. F., & Burt, A. D. (1993). Expression of transforming growth factor alpha in human hepatocellular carcinoma. Liver, 13(3), 151-155.
Scopus30 WoS32 Europe PMC161993 Burt, A. D. (1993). Cellular and molecular aspects of hepatic fibrosis. Journal of Pathology, 170(2), 105-114.
Scopus134 WoS128 Europe PMC891993 Burr, A. W., Carpenter, M. R., Hines, J. E., Gullick, W. J., & Burt, A. D. (1993). Intrahepatic distribution of transforming growth factor‐alpha (TGFα) during liver regeneration following carbon tetrachlorideinduced necrosis. The Journal of Pathology, 170(1), 95-100.
Scopus42 WoS45 Europe PMC261993 Hines, J. E., Johnson, S. J., & Burt, A. D. (1993). In vivo responses of macrophages and perisinusoidal cells to cholestatic liver injury. American Journal of Pathology, 142(2), 511-518.
Scopus142 Europe PMC911993 Collier, J. D., Guo, K., Bassendine, M. F., Major, G. N., & Burt, A. D. (1993). Deficient repair of DNA lesion O<sup>6</sup>-methylguanine in cirrhosis. The Lancet, 341(8839), 207-208.
Scopus13 WoS15 Europe PMC81993 Franceschi, S., Boyle, P., Maisonneuve, P., La Vecchia, C., Burt, A. D., Kerr, D. J., & MacFarlane, G. J. (1993). The epidemiology of thyroid carcinoma.. Critical reviews in oncogenesis, 4(1), 25-52.
Scopus167 WoS140 Europe PMC631993 COLLIER, J. D., MAJOR, G. N., BURT, A. D., & BASSENDINE, M. F. (1993). CHARACTERIZATION OF THE DNA-REPAIR PROTEIN O6-METHYLGUANINE-DNA METHYLTRANSFERASE IN CIRRHOSIS. HEPATOLOGY, 18(4), A182.
1992 Burke, T., Seidler, R., & Smith, H. (1992). Untitled. MOLECULAR ECOLOGY, 1(1), 1.
WoS41992 Johnson, S. J., Hines, J. E., & Burt, A. D. (1992). Phenotypic modulation of perisinusoidal cells following acute liver injury: A quantitative analysis. International Journal of Experimental Pathology, 73(6), 765-772.
Scopus38 WoS36 Europe PMC271992 GRIFFITHS, M. R., SHEPHERD, M., FERRIER, R., SCHUPPAN, D., JAMES, O. F. W., & BURT, A. D. (1992). Light microscopic and ultrastructural distribution of type VI collagen in human liver: alterations in chronic biliary disease. Histopathology, 21(4), 335-344.
Scopus27 WoS23 Europe PMC151992 Burt, A. D. (1992). Liver fibrosis. British Medical Journal, 305(6853), 537-538.
Scopus7 WoS6 Europe PMC41992 Boon, A. P., Hubscher, S. G., Lee, J. A., Hines, J. E., & Burt, A. D. (1992). Hepatic reinnervation following orthotopic liver transplantation in man. The Journal of Pathology, 167(2), 217-222.
Scopus40 WoS33 Europe PMC261992 BLOXHAM, C. A., HENDERSON, D. C., HAMPSON, J., & BURT, A. D. (1992). Nodular regenerative hyperplasia of the liver in Behçet's disease. Histopathology, 20(5), 452-454.
Scopus10 WoS2 Europe PMC21992 Allison, M. C., Mowat, A., McCruden, E. A. B., McGregor, E., Burt, A. D., Briggs, J. D., . . . Mills, P. R. (1992). The spectrum of chronic liver disease in renal transplant recipients. QJM, 83(2), 355-367.
Scopus22 WoS19 Europe PMC81992 Collier, J. D., Guo, K., Mathew, J., May, F. E. B., Bennett, M. K., Corbett, I. P., . . . Burt, A. D. (1992). c-erbB-2 oncogene expression in hepatocellular carcinoma and cholangiocarcinoma. Journal of Hepatology, 14(2-3), 377-380.
Scopus50 WoS45 Europe PMC311992 Johnson, S. J., Hines, J. E., & Burt, A. D. (1992). Immunolocalization of proliferating perisinusoidal cells in rat liver. The Histochemical Journal, 24(2), 67-72.
Scopus20 WoS20 Europe PMC151992 Lee, J. A., Ahmed, Q., Hines, J. E., & Burt, A. D. (1992). Disappearance of hepatic parenchymal nerves in human liver cirrhosis. Gut, 33(1), 87-91.
Scopus48 WoS39 Europe PMC321992 Mathew, J., Cattan, A. R., Hall, A. G., Hines, J. E., Nelson, R., Eastham, E., & Burt, A. D. (1992). Glutathione S-transferases in neonatal liver disease. Journal of Clinical Pathology, 45(8), 679-683.
Scopus22 WoS14 Europe PMC91992 Epstein, M. L., Windebank, K. P., Burt, A. D., Thomas, L., & Cant, A. J. (1992). CD30 expression by peripheral blood monocytes and hepatic macrophages in a child with miliary tuberculosis. Journal of Clinical Pathology, 45(7), 638-639.
Scopus9 WoS9 Europe PMC81992 Johnson, S. J., Hines, J. E., & Burt, A. D. (1992). Macrophage and perisinusoidal cell kinetics in acute liver injury. The Journal of Pathology, 166(4), 351-358.
Scopus115 WoS107 Europe PMC701992 DAY, C. P., BROWN, A. S. M., BENNETT, M. K., BURT, A. D., JAMES, O. F. W., & YEAMAN, S. J. (1992). PLASMA-MEMBRANE PHOSPHATIDATE PHOSPHOHYDROLASE - A ROLE IN LIVER-REGENERATION. HEPATOLOGY, 16(4), A141. 1992 TINIAKOS, D. G., HARRISON, D., & BURT, A. D. (1992). DETECTION OF MALLORY BODIES IN HUMAN LIVER BIOPSIES BY IMMUNOLOCALIZATION OF UBIQUITIN - COMPARISON WITH OTHER HISTOCHEMICAL AND IMMUNOHISTOCHEMICAL METHODS. HEPATOLOGY, 16(2), 601.
WoS11992 TINIAKOS, D., NIKOLAIDOU, A., MOUROUTI, G., LYRA, T., SPANDIDOS, D., & TINIAKOS, G. (1992). ONCOGENE EXPRESSION AND HBV/TUMOR MARKERS IN HUMAN LIVER-DISEASE. HEPATOLOGY, 16(2), 601.
WoS11992 GRIFFITHS, M. R., BURT, A. D., HILLAN, K. J., & MACSWEEN, R. N. M. (1992). LOCALIZATION OF TYPE-I PROCOLLAGEN MESSENGER-RNA IN RAT-LIVER. JOURNAL OF PATHOLOGY, 168, A149. 1992 BURR, A. W., CARPENTER, M. R., & BURT, A. D. (1992). IMMUNOREACTIVE TRANSFORMING GROWTH FACTOR-ALPHA IN RAT-LIVER FOLLOWING ACUTE CARBON TETRACHLORIDE-INDUCED INJURY. HEPATOLOGY, 16(2), 520. 1991 MATHEW, J., HALL, A., CATTAN, A., HINES, J. E., & BURT, A. D. (1991). GLUTATHIONE S-TRANSFERASES IN NEONATAL LIVER-DISEASE. JOURNAL OF PATHOLOGY, 163(2), A178. 1991 JOHNSON, S. J., HINES, J. E., & BURT, A. D. (1991). PERISINUSOIDAL (ITO) CELL-PROLIFERATION AND PHENOTYPIC MODULATION IN ACUTE LIVER-INJURY. GUT, 32(7), A837. 1991 COLLIER, J. D., GUO, K., GULLICK, W. J., CHALLEN, C., BURT, A. D., & BASSENDINE, M. F. (1991). TRANSFORMING GROWTH-FACTOR ALPHA (TGF-ALPHA) - A ROLE IN HUMAN HEPATOCARCINOGENESIS BY AN AUTOCRINE MECHANISM. HEPATOLOGY, 14(4), A110. 1991 AHMED, Q., JOHNSON, S. J., HINES, J. E., & BURT, A. D. (1991). IMMUNOHISTOCHEMICAL LOCALIZATION OF PERISINUSOIDAL (ITO) CELLS IN HUMAN LIVER. JOURNAL OF PATHOLOGY, 163(2), A177. 1991 LEE, J. A., AHMED, Q., HINES, J. E., & BURT, A. D. (1991). ALTERATIONS OF HEPATIC SINUSOIDAL INNERVATION IN LIVER-DISEASE. JOURNAL OF PATHOLOGY, 163(2), A178. 1991 Griffiths, M. R., Keir, S., & Burt, A. D. (1991). Basement membrane proteins in the space of Disse: A reappraisal. Journal of Clinical Pathology, 44(8), 646-648.
Scopus27 WoS25 Europe PMC181991 MURPHY, E., GRIFFITHS, M. R., HUNTER, J. A., & BURT, A. D. (1991). Fibrin‐ring granulomas: a non‐specific reaction to liver injury?. Histopathology, 19(1), 91-93.
Scopus25 WoS8 Europe PMC71991 JOHNSON, S. J., HINES, J. E., & BURT, A. D. (1991). PROLIFERATION OF PERISINUSOIDAL (ITO) CELLS FOLLOWING ACUTE LIVER-INJURY. JOURNAL OF PATHOLOGY, 163(2), A170. 1991 GRIFFITHS, M. R., SCHUPPAN, D., MACSWEEN, R. N. M., FERRIER, R., & BURT, A. D. (1991). LOCALIZATION OF TYPE-VI COLLAGEN IN NORMAL AND FIBROTIC LIVER. JOURNAL OF PATHOLOGY, 163(2), A178. 1990 RAWEILY, E. A., GIBSON, A. A. M., & BURT, A. D. (1990). Abnormalities of intrahepatic bile ducts in extrahepatic biliary atresia. Histopathology, 17(6), 521-527.
Scopus71 WoS50 Europe PMC291990 MYSZOR, M., TURNER, I., MITCHISON, H., BENNETT, M., BURT, A. D., & JAMES, O. F. W. (1990). NO SYMPTOMATIC OR HISTOLOGICAL BENEFIT FROM URSODEOXYCHOLIC ACID TREATMENT IN PBC AFTER 1 YEAR CONTROLLED PILOT-STUDY. HEPATOLOGY, 12(2), 415.
WoS81990 MOWAT, A., ALLISON, M. C., BURT, A. D., MILLS, P. R., BRIGGS, J. D., & MACSWEEN, R. N. M. (1990). CHRONIC LIVER-DISEASE IN RENAL-TRANSPLANT RECIPIENTS. JOURNAL OF PATHOLOGY, 160(2), A169. 1990 RAWEILY, E. A., GIBSON, A. A., & BURT, A. D. (1990). INTRAHEPATIC CHOLANGIOPATHY IN EXTRAHEPATIC BILIARY ATRESIA. JOURNAL OF PATHOLOGY, 160(2), A164. 1990 BURT, A. D., GRIFFITHS, M. R., SCHUPPAN, D., VOSS, B., & MACSWEEN, R. N. M. (1990). Ultrastructural localization of extracellular matrix proteins in liver biopsies using ultracryomicrotomy and immuno‐gold labelling. Histopathology, 16(1), 53-58.
Scopus32 WoS34 Europe PMC231989 Burt, A. D., Tiniakos, D., MacSween, R. N. M., Griffiths, M. R., Wisse, E., & Polak, J. M. (1989). Localization of adrenergic and neuropeptide tyrosine‐containing nerves in the mammalian liver. Hepatology, 9(6), 839-845.
Scopus60 WoS56 Europe PMC451989 Goudie, B. M., Macfarlane, G. J., Boyle, P., Gillis, C. R., MacSween, R. N. M., & Watkinson, G. (1989). Risk Factors and Prognosis in Primary Biliary Cirrhosis. The American Journal of Gastroenterology, 84(7), 713-716.
Scopus68 WoS64 Europe PMC431989 Hillan, K. J., Burt, A. D., George, W. D., Macsween, R. N. M., Griffiths, M. R., & Bradley, J. A. (1989). Intrasplenic hepatocyte transplantation in rats with experimental liver injury: Morphological and morphometric studies. The Journal of Pathology, 159(1), 67-73.
Scopus32 WoS34 Europe PMC231989 BURT, A. D., GRIFFITHS, M. R., SCHUPPAN, D., VOSS, B., & MACSWEEN, R. N. M. (1989). LOCALIZATION OF TYPE-IV COLLAGEN IN HUMAN-LIVER USING IMMUNOELECTRON MICROSCOPY. JOURNAL OF PATHOLOGY, 157(2), A174. 1989 Geerts, A., Vrijsen, R., Rauterberg, J., Burt, A., Schellinck, P., & Wisse, E. (1989). In vitro differentiation of fat-storing cells parallels marked increase of collagen synthesis and secretion. Journal of Hepatology, 9(1), 59-68.
Scopus177 WoS199 Europe PMC1261988 KERR, D. J., REED, N., MACFARLANE, G. J., BOYLE, P., & BURT, A. D. (1988). THE INFLUENCE OF TREATMENT ON SURVIVAL FROM WELL DIFFERENTIATED THYROID-CARCINOMA. BRITISH JOURNAL OF CANCER, 58(2), 272. 1988 BURT, A. D., GRIFFITHS, M., MACSWEEN, R. N. M., SCHUPPAN, D., & VOSS, B. (1988). IDENTIFICATION OF EXTRACELLULAR-MATRIX PROTEINS IN HUMAN-LIVER BIOPSIES USING AN IMMUNOGOLD TECHNIQUE. HEPATOLOGY, 8(5), 1302. 1988 BURT, A. D., GRIFFITHS, M., POLAK, J. M., & MACSWEEN, R. N. M. (1988). PEPTIDERGIC INNERVATION OF THE MAMMALIAN LIVER. HEPATOLOGY, 8(5), 1295.
WoS11988 Verhoeven, D., Buyssens, N., Burt, A. D., & Macsween, R. N. M. (1988). Letters to the editor. The Journal of Pathology, 154(3), 287-288.
Scopus1 Europe PMC11988 HILLAN, K. J., BURT, A. D., MACSWEEN, R. N. M., GEORGE, W. D., & BRADLEY, J. A. (1988). INTRASPLENIC HEPATOCYTE TRANSPLANTATION IN ANIMALS WITH EXPERIMENTAL LIVER-INJURY. HEPATOLOGY, 8(5), 1440. 1988 BURT, A. D., & MACSWEEN, R. N. M. (1988). DESMIN-CONTAINING STELLATE CELLS IN THE RAT-LIVER - REPLY. JOURNAL OF PATHOLOGY, 154(3), 288. 1988 GRIFFITHS, M., BURT, A. D., & MACSWEEN, R. N. M. (1988). LOCALIZATION OF EXTRACELLULAR-MATRIX PROTEINS IN HUMAN-LIVER BY IMMUNO-ELECTRON MICROSCOPY. JOURNAL OF PATHOLOGY, 154(1), A78. 1988 HILLAN, K. J., BURT, A. D., BRADLEY, J. A., GEORGE, W. D., & MACSWEEN, R. N. M. (1988). INTRASPLENIC HEPATOCYTE TRANSPLANTATION IN EXPERIMENTAL LIVER-INJURY - MORPHOMETRICAL AND MORPHOLOGICAL-STUDIES. JOURNAL OF PATHOLOGY, 154(1), A77. 1987 GOUDIE, B. M., MACFARLANE, G., BOYLE, P., BURT, A. D., GILLIS, C. R., MACSWEEN, R. N. M., & WATKINSON, G. (1987). EPIDEMIOLOGY OF ANTIMITOCHONDRIAL ANTIBODY SEROPOSITIVITY AND PRIMARY BILIARY-CIRRHOSIS IN THE WEST OF SCOTLAND. GUT, 28(10), A1346.
WoS131987 BURT, A. D., TINIAKOS, D., MACSWEEN, R. N. M., & POLAK, J. M. (1987). LOCALIZATION OF NEUROPEPTIDE Y CONTAINING NORADRENERGIC NERVES IN MAMMALIAN LIVER. JOURNAL OF PATHOLOGY, 151(1), A67. 1987 HILLAN, K. J., BURT, A. D., MACSWEEN, R. N. M., GEORGE, W. D., & BRADLEY, J. A. (1987). TRANSPLANTATION OF ISOLATED HEPATOCYTES INTO ANIMALS WITH EXPERIMENTAL LIVER-INJURY. JOURNAL OF HEPATOLOGY, 5, S144. 1987 BURT, A. D., GILLON, M., WISSE, E., POLAK, J. M., & MACSWEEN, R. N. M. (1987). DISTRIBUTION OF CALCITONIN GENE RELATED PEPTIDE (CGRP) AND SUBSTANCE P-CONTAINING NERVES IN LIVER - AN IMMUNOHISTOCHEMICAL STUDY. GUT, 28(10), A1330.
WoS31987 Kerr, D. J., Burt, A. D., & Anderson, J. R. (1987). Tumours of the diffuse endocrine system. European Journal of Surgical Oncology, 13(3), 189-195.
Scopus6 WoS4 Europe PMC31987 MacSween, R. N. M., Burt, A. D., & Haboubi, N. Y. (1987). Unusual variant of primary sclerosing cholangitis. Journal of Clinical Pathology, 40(5), 541-545.
Scopus5 WoS7 Europe PMC51987 Burt, A. D., Seywright, M. M., & George, W. D. (1987). Mixed apocrine-medullary carcinoma of the breast. Report of a case with fine needle aspiration cytology. Acta Cytologica, 31(3), 322-324.
Scopus8 WoS7 Europe PMC31987 Burt, A. D., MacGuire, J., Lindop, G. B., & Browne, M. K. (1987). Mixed follicular-parafollicular carcinoma of the thyroid. Scottish Medical Journal, 32(2), 50-51.
Scopus7 WoS3 Europe PMC31987 Burt, A. D., Stewart, J. A., Aitchison, M., & Macsween, R. N. M. (1987). Expression of tissue polypeptide antigen (TPA) in fetal and adult liver: Changes in liver disease. Journal of Clinical Pathology, 40(7), 719-724.
Scopus27 WoS24 Europe PMC161987 Burt, A. D., Cooper, G., MacKay, C., & Boyd, J. F. (1987). Dermoid cyst of the testis. Scottish Medical Journal, 32(5), 146-148.
Scopus12 WoS5 Europe PMC71987 CONNELL, J. M. C., CORDER, R., ASBURY, J., MACPHERSON, S., INGLIS, G. C., LOWRY, P., . . . SEMPLE, P. F. (1987). NEUROPEPTIDE Y IN MULTIPLE ENDOCRINE NEOPLASIA: RELEASE DURING SURGERY FOR PHAEOCHROMOCYTOMA. Clinical Endocrinology, 26(1), 75-84.
Scopus12 WoS12 Europe PMC101987 BURT, A. D., STEWART, J., & MACSWEEN, R. N. M. (1987). IMMUNOLOCALIZATION OF TISSUE POLYPEPTIDE ANTIGEN (TPA) IN HUMAN-LIVER BIOPSIES. JOURNAL OF PATHOLOGY, 151(1), A67. 1987 HILLAN, K. J., BURT, A. D., GEORGE, W. D., & BRADLEY, J. A. (1987). FAILURE OF HEPATOCYTE TRANSPLANTATION TO IMPROVE SURVIVAL IN AN EXPERIMENTAL-MODEL OF CHRONIC LIVER-INJURY. JOURNAL OF HEPATOLOGY, 5, S144. 1986 BURT, A. D., TINIAKOS, D., MACSWEEN, R. N. M., & POLAK, J. M. (1986). NEUROPEPTIDE TYROSINE (NPY) IMMUNOREACTIVITY IN INTRAHEPATIC NERVES IN RAT AND HUMAN-LIVER. JOURNAL OF PATHOLOGY, 148(1), A67. 1986 Goudie, B. M., Burt, A. D., Macfarlane, G., Birnie, G. G., Macsween, R. N. M., & Watkinson, G. (1986). Breast cancer in women with primary biliary cirrhosis. British Medical Journal (Clinical research ed.), 292(6516), 341.
1986 Burt, A. D., & MacSween, R. N. M. (1986). Hepatic vein lesions in alcoholic liver disease: Retrospective biopsy and necropsy study. Journal of Clinical Pathology, 39(1), 63-67.
Scopus67 WoS36 Europe PMC231986 Burt, A. D., Robertson, J. L., Heir, J., & Macsween, R. N. M. (1986). Desmin‐containing stellate cells in rat liver; distribution in normal animals and response to experimental acute liver injury. The Journal of Pathology, 150(1), 29-35.
Scopus113 WoS117 Europe PMC741986 Kerr, D. J., Burt, A. D., Boyle, P., MacFarlane, G. J., Storer, A. M., & Brewin, T. B. (1986). Prognostic factors in thyroid tumours. British Journal of Cancer, 54(3), 475-482.
Scopus37 WoS40 Europe PMC221986 GOUDIE, B. M., BURT, A. D., MACFARLANE, G., BIRNIE, G. G., MACSWEEN, R. N. M., WATKINSON, G., . . . GILLIS, C. R. (1986). BREAST-CANCER IN WOMEN WITH PRIMARY BILIARY-CIRRHOSIS - REPLY. BRITISH MEDICAL JOURNAL, 292(6516), 340-341.
Europe PMC11986 Hollman, A. S., Morley, P., Burt, A. D., & Davidson, J. K. (1986). Biliary tract dilatation in acquired immune deficiency syndrome. European Journal of Radiology, 6(4), 309-310.
Scopus1 WoS4 Europe PMC11986 MacSween, R. N. M., & Burt, A. D. (1986). Histologic spectrum of alcoholic liver disease. Seminars in Liver Disease, 6(3), 221-232.
Scopus219 WoS184 Europe PMC1321986 Burt, A. D., Smillie, D., Cowan, M. D., & Adams, F. G. (1986). Fine needle aspiration cytology: experience with a cell block technique.. Journal of clinical pathology, 39(1), 114-115.
Scopus15 WoS16 Europe PMC91986 Kerr, D. J., Burt, A. D., Beastall, G. H., & Holloway, C. D. (1986). The effect of 5-fluorouracil on rat adrenal function. Medical Oncology and Tumor Pharmacotherapy, 3(2), 101-104.
Scopus1 WoS1 Europe PMC11986 ROBERTSON, J. L., BURT, A. D., & MACSWEEN, R. N. M. (1986). MORPHOMETRICAL STUDY OF DESMIN-CONTAINING NONPARENCHYMAL CELLS IN EXPERIMENTAL ACUTE LIVER-INJURY. JOURNAL OF PATHOLOGY, 148(1), A66. 1986 BURT, A. D., STEWART, J., & MACSWEEN, R. N. M. (1986). IMMUNOLOCALIZATION OF TISSUE POLYPEPTIDE ANTIGEN (TPA) IN HUMAN-LIVER BIOPSIES. HEPATOLOGY, 6(4), 802. 1986 GOUDIE, B. M., BURT, A. D., MACFARLANE, G., BOYLE, P., MACSWEEN, R. M. N., WATKINSON, G., & GILLIS, C. R. (1986). FACTORS AFFECTING THE PROGNOSIS OF PRIMARY BILIARY-CIRRHOSIS. DIGESTIVE DISEASES AND SCIENCES, 31(10), S476. 1986 PLUMB, J. A., WILMOTT, N., KERR, D. J., BURT, A. D., MORE, I. A. R., & KAYE, S. B. (1986). FLUORESCENT MICROSCOPIC STUDIES ON THE DIFFERENTIAL CELLULAR-DISTRIBUTION OF ADRIAMYCIN AND 4'-DEOXYDOXORUBICIN. BRITISH JOURNAL OF CANCER, 53(3), 440. 1986 BURT, A. D., ROBERTSON, J. L., & MACSWEEN, R. N. M. (1986). IDENTIFICATION OF DESMIN-CONTAINING NONPARENCHYMAL CELLS IN RAT-LIVER. JOURNAL OF PATHOLOGY, 148(1), A65-A66. 1986 GOUDIE, B. M., BURT, A. D., MACFARLANE, G., BOYLE, P., MACSWEEN, R. N. M., GILLIS, C. R., & WATKINSON, G. (1986). THE NATURAL-HISTORY OF PRIMARY BILIARY-CIRRHOSIS. SCOTTISH MEDICAL JOURNAL, 31(1), 60. 1985 BURT, A. D., & MACSWEEN, R. N. M. (1985). VENO-OCCLUSIVE LESIONS IN ALCOHOLIC LIVER-DISEASE. JOURNAL OF PATHOLOGY, 145(1), A87. 1985 BURT, A. D., BROWN, I. L., KERR, D. J., & BOYLE, P. (1985). IMMUNOHISTOCHEMICAL DEMONSTRATION OF EPITHELIAL AND LYMPHOID MARKERS IN ANAPLASTIC THYROID-TUMORS. SCOTTISH MEDICAL JOURNAL, 30(1), 56. 1985 BURT, A. D., KERR, D. J., BROWN, I. L., & BOBROW, L. G. (1985). HISTOGENESIS OF ANAPLASTIC THYROID-TUMORS. BRITISH JOURNAL OF CANCER, 52(3), 447-448. 1985 Burt, A. D., Kerr, D. J., Brown, I. L., & Boyle, P. (1985). Lymphoid and epithelial markers in small cell anaplastic thyroid tumours. Journal of Clinical Pathology, 38(8), 893-896.
Scopus18 WoS19 Europe PMC121985 Kerr, D. J., Burt, A. D., Brewin, T. B., & Boyle, P. (1985). DIVERGENCE BETWEEN MORTALITY AND INCIDENCE RATES OF THYROID CANCER IN SCOTLAND. The Lancet, 326(8447), 149.
Scopus7 WoS9 Europe PMC41985 MacSween, R. N. M., & Burt, A. D. (1985). The cellular pathology of primary biliary cirrhosis. Molecular Aspects of Medicine, 8(3), 269-291.
Scopus15 WoS12 Europe PMC91985 Goudie, B. M., Burt, A. D., Macfarlane, G., Birnie, G. G., Mills, P. R., Macsween, R. N. M., . . . Gillis, C. R. (1985). Breast cancer in women with primary biliary cirrhosis. British Medical Journal (Clinical research ed.), 291(6509), 1597-1598.
Scopus57 WoS51 Europe PMC331984 Burt, A. D., & Goudie, R. B. (1984). Thyroglobulin in carcinoma of the thyroid. Human Pathology, 15(2), 197-198.
Scopus3 WoS4 Europe PMC31984 Burt, A. D., Scott, G., Shiach, C. R., & Isles, C. G. (1984). Acquired immunodeficiency syndrome in a patient with no known risk factors: A pathological study. Journal of Clinical Pathology, 37(4), 471-474.
Scopus19 WoS25 Europe PMC141984 Behan, W. M. H., & Burt, A. D. (1984). HTLV-III SEROPOSITIVITY IN AIDS. The Lancet, 323(8389), 1292.
Scopus1 WoS2 Europe PMC11984 Shiach, C. R., Burt, A. D., Isles, C. G., & Ball, S. G. (1984). Pyrexia of undetermined origin, diarrhoea, and primary cerebral lymphoma associated with acquired immunodeficiency. British Medical Journal, 288(6415), 449-450.
Scopus11 WoS7 Europe PMC61984 BURT, A. D., BROWN, I. L., STEWART, J., & KERR, D. J. (1984). IMMUNOHISTOCHEMICAL STUDY OF ANAPLASTIC SMALL CELL TUMORS OF THYROID. JOURNAL OF PATHOLOGY, 143(4), A296. 1982 Burt, A. D., Anthony, R. S., Hislop, W. S., Bouchier, I. A., & MacSween, R. N. (1982). Liver membrane antibodies in alcoholic liver disease: I. Prevalence and immunoglobulin class. Gut, 23(3), 221-225.
Scopus40 WoS37 Europe PMC181981 MacSween, R., Burt, A., Anthony, R., & Hislop, W. (1981). Liver membrane antibodies in alcoholic liver disease. Journal of Pathology, 134(4), 332. 1980 Burt, A., MacSween, R. N. M., Galbraith, I., & Hislop, W. S. (1980). Liver membrane antibodies in alcoholic liver disease. Scottish Medical Journal, 25(2), 163-164.
Scopus51979 BURT, A., & GOUDIE, R. B. (1979). Diagnosis of primary thyroid carcinoma by immunohistological demonstration of thyroglobulin. Histopathology, 3(4), 279-286.
Scopus69 WoS78 Europe PMC49 -
Books
Year Citation 2023 Burt, A., Ferrell, L. D., & Hübscher, S. G. (2023). MacSween's Pathology of the Liver, Eighth Edition. Elsevier.
DOI Scopus12018 Burt, A. D., Ferrell, L. D., & Hübscher, S. G. (Eds.) (2018). MacSween's Pathology of the Liver (7 ed.).
Scopus252018 Burt, A. D., Ferrell, L. D., & Hübscher, S. G. (Eds.) (2018). MacSween's Pathology of the Liver (7 ed.).
Scopus252011 Burt, A. D., Portmann, B. C., & Ferrell, L. D. (2011). Preface.
DOI2011 Burt, A. D., Portmann, B. C., & Ferrell, L. D. (Eds.) (2011). MacSween's pathology of the liver (6 ed.). Churchill Livingstone/Elsevier.
DOI Scopus692011 Burt, A. D., Portmann, B. C., & Ferrell, L. D. (Eds.) (2011). MacSween's pathology of the liver (6 ed.). Churchill Livingstone/Elsevier.
DOI Scopus69 -
Book Chapters
Year Citation 2023 Bellamy, C. O. C., & Burt, A. D. (2023). Liver in Systemic Disease. In MacSween's Pathology of the Liver, Eighth Edition (pp. 1039-1095). Elsevier.
DOI2023 Tiniakos, D. G., Anstee, Q. M., Brunt, E. M., & Burt, A. D. (2023). Fatty Liver Disease. In MacSween's Pathology of the Liver, Eighth Edition (pp. 330-401). Elsevier.
DOI Scopus42018 Tiniakos, D. G., Anstee, Q. M., & Burt, A. D. (2018). Fatty Liver Disease. In A. D. Burt, L. D. Ferrell, & S. G. Hubscher (Eds.), MacSween's Pathology of the Liver (7 ed., pp. 308-371). Elsevier.
DOI Scopus212018 Burt, A. D., Ferrell, L. D., & Hübscher, S. G. (2018). Preface. In A. D. Burt, L. D. Ferrell, & S. G. Hubscher (Eds.), MacSween's Pathology of the Liver (7 ed., pp. v-vi). Elselvier.
DOI Scopus72018 Bellamy, C., & Burt, A. D. (2018). The Liver in Systemic Disease. In A. D. Burt, L. D. Ferrell, & S. G. Hubscher (Eds.), MacSween's Pathology of the Liver (7 ed., pp. 966-1018). Elsevier.
DOI Scopus72012 Burt, A. D., Portmann, B. C., & Ferrell, L. D. (2012). Preface. In A. D. Burt, B. C. Portmann, & L. D. Ferrell (Eds.), MacSween's pathology of the liver (6 ed., pp. xi). Elsevier.
DOI2011 Brunt, E. M., Neuschwander-Tetri, B. A., & Burt, A. D. (2011). Fatty Liver Disease: Alcoholic and Non-Alcoholic. In MacSween's Pathology of the Liver: Expert Consult: Online and Print (pp. 293-359). Elsevier.
DOI Scopus352011 Quaglia, A., Burt, A. D., Ferrell, L. D., & Portmann, B. C. (2011). Systemic Disease. In MacSween's Pathology of the Liver: Expert Consult: Online and Print (pp. 935-986). Elsevier.
DOI Scopus32011 Crawford, J. M., & Burt, A. D. (2011). Anatomy, Pathophysiology and Basic Mechanisms of Disease. In MacSween's Pathology of the Liver: Expert Consult: Online and Print (pp. 1-77). Elsevier.
DOI Scopus26 -
Conference Papers
Year Citation 2023 McNeil, C., Wong, P. F., Sridhar, N., Wang, Y., Santori, C., Wu, C. H., . . . Cimermancic, P. (2023). AI-enabled virtual hematoxylin and eosin and Masson's trichrome staining for non-alcoholic fatty liver disease activity scoring from single unstained slide. In JOURNAL OF HEPATOLOGY Vol. 78 (pp. S671-S672). ELSEVIER. 2022 Vacca, M., Kamzolas, I., Harder, L. M., Oakley, F., Trautwein, C., Hatting, M., . . . Vidal-Puig, A. (2022). Is there a murine model that fully recapitulates human NASH? An unbiased bioinformatics approach to rank pre-clinical models based on proximity to human disease. In JOURNAL OF HEPATOLOGY Vol. 77 (pp. S7-S8). ELSEVIER. 2022 Mauricio, J., Murphy, S., McCain, M., Geh, D., Kadharusman, M., Leslie, J., . . . Reeves, H. L. (2022). Hepatocellular carcinoma and neutrophils-towards understanding positive and negative impacts on treatments and progression. In JOURNAL OF HEPATOLOGY Vol. 77 (pp. S646-S647). ELSEVIER. 2022 Burt, A. D., Carey, C., Jones, C., Ness, T., Coulthard, R., Bennick, L., . . . Kirkness, M. (2022). Collagen Hybridising Peptides Reliably Detect Total and Degraded Collagen in Human Liver Biopsies and May Provide Prognostic Information. In JOURNAL OF PATHOLOGY Vol. 256 (pp. S11). ELECTR NETWORK: WILEY. 2021 Van Haele, M., Younes, R., Cockell, S., Palmer, J., Ostyn, T., Wouters, J., . . . Govaere, O. (2021). Pro-inflammatory hepatic progenitor cell response is associated with progression of human non-alcoholic fatty liver disease. In JOURNAL OF HEPATOLOGY Vol. 75 (pp. S266). ELSEVIER. 2020 Govaere, O., McPherson, S., Younes, R., Tiniakos, D., Pais, R., Bedossa, P., . . . Anstee, Q. (2020). A transcriptomic signature predicting fibrosis progression in a large European cohort of patients with histologically characterised NAFLD. In JOURNAL OF HEPATOLOGY Vol. 73 (pp. S109-S110). ELSEVIER. 2020 Cottingham, S. W., Mauricio-Muir, J., McCain, M. V., Watson, R., Evans, C., Wilson, C., . . . Reeves, H. (2020). ELEVATED NUMBERS AND SIZE OF AGGREGATES OF IMMUNE CELLS PROTECTS AGAINST LIVER CANCER PROGRESSION. In GUT Vol. 69 (pp. A38). ELECTR NETWORK: BMJ PUBLISHING GROUP.
DOI2020 Mauricio-Muir, J., McCain, M., Watson, R., Masson, S., McPherson, S., Burt, A., . . . Reeves, H. L. (2020). ELEVATED INTRATUMOUR NEUTROPHILS ASSOCIATE WITH IMPROVED TREATMENT RESPONSES AND PROGNOSIS IN PATIENTS WITH HCC. In GUT Vol. 69 (pp. A32). ELECTR NETWORK: BMJ PUBLISHING GROUP.
DOI2019 Tian, Y., Pu, L. Z. C. T., Singh, R., Burt, A. D., & Carneiro, G. (2019). One-stage five-class polyp detection and. In 2019 IEEE 16th International Symposium on Biomedical Imaging (ISBI) Vol. 2019-April (pp. 70-73). online: IEEE.
DOI Scopus25 WoS82018 Pu, L. Z. C. T., Campbell, B., Burt, A. D., Carneiro, G., & Singh, R. (2018). COMPUTER-AIDED DIAGNOSIS FOR CHARACTERISING COLORECTAL LESIONS: INTERIM RESULTS OF A NEWLY DEVELOPED SOFTWARE. In GASTROINTESTINAL ENDOSCOPY Vol. 87 (pp. AB245). Washington, DC: MOSBY-ELSEVIER.
WoS32018 Pu, L. Z. C. T., Lu, K., Ovenden, A., Edwards, S., Wilson, B., Carneiro, G., . . . Singh, R. (2018). EFFECT OF TRAINING AND TIME OF THE DAY ON POLYP DETECTION RATES IN AUSTRALIA. In GASTROINTESTINAL ENDOSCOPY Vol. 87 (pp. AB161). Washington, DC: MOSBY-ELSEVIER. 2018 Pu, L. Z. C. T., Koay, D. S., Ovenden, A., Singh, G., Rana, K., Burt, A. D., & Singh, R. (2018). OPTICAL EVALUATION OF SCARS AFTER EMR USING NBI WITH DUAL FOCUS AND UNDERWATER TECHNIQUE (UNBI-DF): INTERIM ANALYSIS. In GASTROINTESTINAL ENDOSCOPY Vol. 87 (pp. AB377). Washington, DC: MOSBY-ELSEVIER. 2017 Pu, L. Z. C. T., Koay, D. S. C., Ovenden, A., Burt, A. D., & Singh, R. (2017). Prospective study to evaluate scars after colorectal endoscopic mucosal resection using narrow-band imaging with dual focus and underwater technique: Interim analysis. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 32 (pp. 33-34). WILEY. 2017 Pu, L. Z. C. T., Campbell, B., Carneiro, G., Burt, A. D., & Singh, R. (2017). Computer-aided diagnosis (CAD) for characterizing colorectal lesions: Initial results of newly developed software. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 32 (pp. 34-35). WILEY. 2017 Pu, L. Z. C. T., Koay, D. S. C., Ovenden, A., Burt, A. D., & Singh, R. (2017). Prospective study predicting histology in colorectal lesions: Interim analysis of the NICE, JNET, and MS classifications. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 32 (pp. 34). WILEY. 2015 Wahed, S., Disep, B., Peace, R., Burt, A., & Griffin, M. (2015). Minimally Invasive Sentinel Lymph Node Biopsy in Oesophageal Adenocarcinoma. In BRITISH JOURNAL OF SURGERY Vol. 102 (pp. 4). Manchester, ENGLAND: WILEY-BLACKWELL. 2013 Tanwar, S., Parkes, J., Hogan, B. J., Schuppan, D., Pinzani, M., Arthur, M. J. P., . . . Rosenberg, W. M. (2013). FURTHER VALIDATION OF TERMINAL PEPTIDE OF PROCOLLAGEN III (PIIINP) FOR THE DETECTION AND ASSESSMENT OF NONALCOHOLIC STEATOHEPATITIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE. In GUT Vol. 62 (pp. A188). Glasgow, SCOTLAND: BMJ PUBLISHING GROUP.
DOI2013 Tanwar, S., Parkes, J., Trembling, P. M., Hogan, B. J., Schuppan, D., Pinzani, M., . . . Rosenberg, W. M. (2013). FURTHER VALIDATION OF TERMINAL PEPTIDE OF PROCOLLAGEN III (PIIINP) FOR THE DETECTION AND ASSESSMENT OF NONALCOHOLIC STEATOHEPATITIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE. In JOURNAL OF HEPATOLOGY Vol. 58 (pp. S550). Amsterdam, NETHERLANDS: ELSEVIER SCIENCE BV.
DOI2013 Liu, Y. -L., Patman, G., Leathart, J., Burt, A., Day, C. P., Daly, A. K., . . . Anstee, Q. M. (2013). CARRIAGE OF PNPLA3 I148M IS ASSOCIATED WITH AN INCREASED RISK OF NON-ALCOHOLIC FATTY LIVER DIESEASE ASSOCIATED HEPATOCELLULAR CARCINOMA. In JOURNAL OF HEPATOLOGY Vol. 58 (pp. S516). Amsterdam, NETHERLANDS: ELSEVIER SCIENCE BV.
DOI WoS82013 Brain, J., Masson, S., & Burt, A. (2013). TRANSPLANTATION FOR ALD: LESSONS FROM THE EXPLANT. In JOURNAL OF HEPATOLOGY Vol. 58 (pp. S213). Amsterdam, NETHERLANDS: ELSEVIER SCIENCE BV.
DOI2013 Anstee, Q. M., Darlay, R., Leathart, J., Liu, Y. -L., Tordjman, J., Clement, K., . . . Day, C. P. (2013). A CANDIDATE-GENE APPROACH TO VALIDATION OF GENETIC MODIFIER ASSOCIATIONS USING A LARGE COHORT WITH HISTOLOGICALLY CHARACTERISED NON-ALCOHOLIC FATTY LIVER DISEASE. In JOURNAL OF HEPATOLOGY Vol. 58 (pp. S46). Amsterdam, NETHERLANDS: ELSEVIER SCIENCE BV.
DOI WoS102013 Bedossa, P., Gouw, A., Lackner, C., Schirmacher, P., Terraciano, L., Tiniakos, D., & Burt, A. (2013). APPLICATION, UTILITY AND VALIDATION OF A NEW HISTOLOGICAL SYSTEM FOR CLASSIFICATION OF NAFLD IN PATIENTS WITH METABOLIC SYNDROME. In JOURNAL OF HEPATOLOGY Vol. 58 (pp. S33). Amsterdam, NETHERLANDS: ELSEVIER SCIENCE BV.
DOI2013 Brain, J., Thompson, E., Jones, D., Burt, A., & Kirby, J. (2013). Transplantation: Do Senescence and Autophagy Modulate the Development of Chronic Pathology.. In AMERICAN JOURNAL OF TRANSPLANTATION Vol. 13 (pp. 505). Seattle, WA: WILEY-BLACKWELL. 2012 Tanwar, S., Trembling, P. M., Thorburn, D., Guha, I. N., Parkes, J., Kaye, P., . . . Rosenberg, W. M. (2012). DIRECT SERUM MARKERS ARE MORE ACCURATE THAN SIMPLE MARKER PANELS FOR THE DETECTION OF FIBROSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD). In GUT Vol. 61 (pp. A414). B M J PUBLISHING GROUP.
DOI2012 Masson, S., Emmerson, I., Henderson, E., Fletcher, E., Burt, A., Day, C., & Stewart, S. (2012). CLINICAL BUT NOT HISTOLOGICAL FACTORS PREDICT LONG-TERM PROGNOSIS IN PATIENTS WITH BIOPSY PROVEN ADVANCED ALCOHOLIC LIVER DISEASE. In GUT Vol. 61 (pp. A413-A414). Liverpool, ENGLAND: B M J PUBLISHING GROUP.
DOI WoS12012 Robinson, S., Wilson, C., Burt, A., Manas, D., & White, S. (2012). CHEMOTHERAPY ASSOCIATED LIVER INJURY: A SYSTEMATIC REVIEW AND META-ANALYSIS. In GUT Vol. 61 (pp. A357). B M J PUBLISHING GROUP.
DOI2012 Robinson, S., Mann, J., Manas, D., Burt, A., Mann, D., & White, S. (2012). AN EXPERIMENTAL STUDY TO DETERMINE THE PATHOGENESIS OF OXALIPLATIN INDUCED SINUSOIDAL OBSTRUCTION SYNDROME. In GUT Vol. 61 (pp. A26). B M J PUBLISHING GROUP.
DOI2012 McPherson, S., Griffiths, L., Hardy, T., Henderson, E., Burt, A., Day, C., & Anstee, Q. M. (2012). THE FIB-4 SCORE RELIABLY EXCLUDES ADVANCED FIBROSIS IN A DIABETIC COHORT WITH NAFLD. In JOURNAL OF HEPATOLOGY Vol. 56 (pp. S515-S516). Barcelona, SPAIN: ELSEVIER SCIENCE BV.
DOI2012 Tanwar, S., Trembling, P. M., Thorburn, D., Guha, I. N., Parkes, J., Kaye, P., . . . Rosenberg, W. M. (2012). DIRECT SERUM MARKERS ARE MORE ACCURATE THAN SIMPLE MARKER PANELS FOR THE DETECTION OF FIBROSIS IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD). In JOURNAL OF HEPATOLOGY Vol. 56 (pp. S423). Barcelona, SPAIN: ELSEVIER SCIENCE BV. 2011 Prentis, J., McPherson, S., Burt, A., Manas, D., Snowden, C., Hudson, M., & Masson, S. (2011). PRE-TRANSPLANT HISTOLOGICAL ASSESSMENT IN PATIENTS WITH ALCOHOLIC LIVER DISEASE DOES NOT PREDICT RISK OF RECIDIVISM POST LIVER TRANSPLANTATION. In GUT Vol. 60 (pp. A37-A38). BMJ PUBLISHING GROUP.
DOI2011 Tanwar, S., Trembling, P., Guha, I. N., Parkes, J., Kaye, P., Burt, A. D., . . . Rosenberg, W. M. (2011). VALIDATION OF A NOVEL BIOMARKER MODEL FOR THE PREDICTION OF NON-ALCOHOLIC STEATOHEPATITIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE. In GUT Vol. 60 (pp. A4-A5). BMJ PUBLISHING GROUP.
DOI2011 McPherson, S., Anstee, Q., Henderson, E., Burt, A., & Day, C. (2011). ARE SIMPLE NON-INVASIVE SCORING SYSTEMS FOR FIBROSIS RELIABLE IN PATIENTS WITH NAFLD AND NORMAL ALT LEVELS?. In GUT Vol. 60 (pp. A54-A55). BMJ PUBLISHING GROUP.
DOI2011 Leavitt, M., Burt, A. D., Hu, W., Canty, D., Gray, M., Bray, A., . . . Quinn, A. G. (2011). RECOMBINANT LYSOSOMAL ACID LIPASE NORMALIZES LIVER WEIGHT, TRANSAMINASES AND HISTOPATHOLOGICAL ABNORMALITIES IN AN <i>IN VIVO</i> MODEL OF CHOLESTERYL ESTER STORAGE DISEASE. In JOURNAL OF HEPATOLOGY Vol. 54 (pp. S358). Berlin, GERMANY: ELSEVIER.
DOI WoS102011 Robinson, S. M., Mann, J., Burt, A. D., Manas, D. M., Mann, D. A., & White, S. A. (2011). Pathogenesis of chemotherapy associated liver injury prior to major hepatic resection. In BRITISH JOURNAL OF SURGERY Vol. 98 (pp. 20). Royal Coll Surgery, Dublin, IRELAND: WILEY-BLACKWELL. 2011 Wallace, K., Shaw, J., White, S. A., Wright, S., Burt, A. D., & Wright, M. C. (2011). PROLONGED GLUCOCORTICOID EXPOSURE RESULTS IN THE APPEARANCE OF HEPATOCYTES IN THE ADULT PANCREAS. In JOURNAL OF HEPATOLOGY Vol. 54 (pp. S435). Berlin, GERMANY: ELSEVIER. 2011 Tanwar, S., Trembling, P. M., Guha, I. N., Parkes, J., Kaye, P., Burt, A. D., . . . Rosenberg, W. M. (2011). VALIDATION OF A NOVEL BIOMARKER MODEL FOR THE PREDICTION OF NON-ALCOHOLIC STEATOHEPATITIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE. In HEPATOLOGY Vol. 54 (pp. 1123A). San Francisco, CA: WILEY-BLACKWELL. 2011 Jennings, N. A., Burt, A. D., & Griffin, S. M. (2011). Lymph node metastases in early oesophageal adenocarcinoma. In BRITISH JOURNAL OF SURGERY Vol. 98 (pp. 91). Bournemouth, ENGLAND: WILEY-BLACKWELL. 2011 Zeybel, M., Oakley, F., Burt, A. D., Mann, D. A., & Mann, J. (2011). PROTECTIVE ADAPTATION TO LIVER FIBROSIS IN A SINGLE GENERATION BY HERITABLE EPIGENETIC MODIFICATIONS. In JOURNAL OF HEPATOLOGY Vol. 54 (pp. S52-S53). Berlin, GERMANY: ELSEVIER.
DOI2011 Koshy, A., Knisely, A., Robinson, S. M., White, S., & Burt, A. D. (2011). Bile Canalicular Protein Expression is Altered in Chemotherapy-induced Sinusoidal Obstruction Syndrome (SOS). In JOURNAL OF PATHOLOGY Vol. 224 (pp. S37). Univ Ghent, Dept Pathol, Onderbergen, BELGIUM: WILEY-BLACKWELL. 2011 Brain, J., Burt, A. D., Kirby, J. A., & Robertson, H. (2011). Investigation of the Fate of Cholangiocytes in Cholestatic Liver Disease. In JOURNAL OF PATHOLOGY Vol. 224 (pp. S22). Univ Cambridge, Dept Pathol, Cambridge, ENGLAND: WILEY-BLACKWELL. 2011 McPherson, S., Anstee, Q. M., Henderson, E., Burt, A. D., & Day, C. P. (2011). ARE SIMPLE NON-INVASIVE SCORING SYSTEMS FOR FIBROSIS RELIABLE IN PATIENTS WITH NAFLD AND NORMAL ALT LEVELS?. In HEPATOLOGY Vol. 54 (pp. 1125A). San Francisco, CA: WILEY-BLACKWELL.
WoS12010 Mann, J., Oakley, F., Burt, A. D., Tsukamoto, H., & Mann, D. (2010). EPIGENETIC REGULATION OF PRO-FIBROGENIC GENES INVOLVED IN HEPATIC STELLATE CELL ACTIVATION AND LIVER FIBROSIS. In HEPATOLOGY Vol. 52 (pp. 1267A). Boston, MA: WILEY-BLACKWELL. 2010 Chakraborty, J. B., Mann, J., Oakley, F., Burt, A. D., & Mann, D. A. (2010). NF-KB1 (P50) PROTECTS AGAINST GROWTH OF HEPATOCELLULAR CARCINOMA BY SUPPRESSING ROS, INHIBITING HEPATIC PHOSPHOSTAT3 AND STIMULATING PHOSPHOP38α. In HEPATOLOGY Vol. 52 (pp. 593A). Boston, MA: WILEY-BLACKWELL. 2010 Wright, M. C., Wallace, K., Shaw, J. A., Burt, A. D., & White, S. A. (2010). Long term glucocorticoid therapy leads to pancreatic acinar trans-differentiation into hepatocyte-like cells. In BRITISH JOURNAL OF SURGERY Vol. 97 (pp. 28). Royal Free Hosp, London, ENGLAND: JOHN WILEY & SONS LTD. 2010 White, S. A., Shaw, J. A., Flecknell, P. A., Burt, A. D., & Wright, M. C. (2010). Chronic elevated systemic glucocorticoid results in widespread pancreatic-hepatic trans-differentiation <i>in vivo</i>. In TOXICOLOGY Vol. 278 (pp. 347). Herriot Watt Univ, Edinburgh, ENGLAND: ELSEVIER IRELAND LTD.
DOI2009 Mann, J., Xu, X., Oakley, F., Maxwell, A., Elsharkawy, A. M., Mann, D. A., & Burt, A. D. (2009). EPIGENETICALLY INHERITED RESISTANCE TO LIVER FIBROSIS. In HEPATOLOGY Vol. 50 (pp. 849A-850A). Boston, MA: JOHN WILEY & SONS INC.
WoS22009 McGee, K. C., Harte, A. L., Hill, M. J., Burt, A. D., Kumar, S., Day, C. P., & McTernan, P. G. (2009). Circulating visfatin levels reduced in patients with non-alcoholic fatty liver disease irrespective of type 2 diabetes mellitus status. In DIABETOLOGIA Vol. 52 (pp. S20-S21). Vienna, AUSTRIA: SPRINGER. 2009 Al-Rifai, A., Henderson, E., De Alwis, N., Burt, A. D., Day, C. P., & Stewart, S. (2009). STEATOSIS AND INFLAMMATION ARE TOGETHER ASSOCIATED WITH FIBROSIS PROGRESSION IN PATIENTS WITH NASH. In HEPATOLOGY Vol. 50 (pp. 802A). Boston, MA: JOHN WILEY & SONS INC. 2009 Wallace, K., White, S. A., Shaw, J. A., Burt, A. D., & Wright, M. C. (2009). CHRONIC ELEVATED SYSTEMIC GLUCOCORTICOCOID RESULTS IN WIDESPREAD PANCREATIC-HEPATIC TRANS-DIFFERENTIATION IN VIVO. In HEPATOLOGY Vol. 50 (pp. 899A). Boston, MA: JOHN WILEY & SONS INC. 2009 Gieling, R. G., Rajasekaran, V., Jurk, D., Elsharkawy, A. M., Burt, A. D., Oakley, F., & Mann, D. A. (2009). THE ANTI-INFLAMMATORY AND ANTI-PROLIFERATIVE PROPERTIES OF THE NFKB1 (P50) GENE PROTECT AGAINST HEPATOCELLULAR CARCINOMA. In HEPATOLOGY Vol. 50 (pp. 881A). Boston, MA: JOHN WILEY & SONS INC. 2008 Marshall, H. L., Robertson, H., Burt, A. D., Jones, D. E. J., Kirby, J. A., & Hudson, M. (2008). Biliary epithelial to mesenchymal transition contributes to portal tract fibrogenesis in primary sclerosing cholangitis. In GUT Vol. 57 (pp. A50-A51). Brimingham, ENGLAND: B M J PUBLISHING GROUP. 2008 Elsharkawy, A. M., Gieling, R. G., Oakley, F., Kendall, T., Burt, A. D., & Mann, D. A. (2008). Attenuated inflammatory response in fibrotic livers of mice lacking the c-Rel subunit of NF-kB. In JOURNAL OF HEPATOLOGY Vol. 48 (pp. S22-S23). Milan, ITALY: ELSEVIER SCIENCE BV.
DOI2008 Kendrick, S., Leathart, J. B., Henderson, E., De Alwis, N., Stewart, S., Burt, A. D., . . . Day, C. P. (2008). A 'LOSS-OF-FUNCTION' MUTATION IN TIRAP, THE GENE ENCODING THE TOLL-LIKE RECEPTOR ADAPTER MOLECULE MAL PROTECTS AGAINST FIBROSIS IN NAFLD BUT NOT ALD. In HEPATOLOGY Vol. 48 (pp. 334A-335A). San Francisco, CA: JOHN WILEY & SONS INC.
WoS12007 Newton, J. L., Jones, D. E., Kane, L., Henderson, E., Pairman, J., Wilton, K., . . . Day, C. P. (2007). Fatigue in NAFLD is severe and associates with excessive daytime somnolence but not with liver disease severity or insulin resistance. In HEPATOLOGY Vol. 46 (pp. 742A-743A). Boston, MA: JOHN WILEY & SONS INC. 2007 van der Laan, L. J. W., Thomas, R. C., Zondervan, P. E., Lindsay, A. S., Burt, A. D., Hudson, M., . . . Metselaar, H. J. (2007). The effect of calcineurin inhibitor usage on hepatic fibrosis progression in HCV-positive liver transplant recipients: A two-centre study.. In LIVER TRANSPLANTATION Vol. 13 (pp. S152). Rio de Janeiro, BRAZIL: JOHN WILEY & SONS INC.
WoS12006 Price, D. A., Donaldson, P. T., Ann, D. K., Leathart, J. B., Burt, A. D., Schmid, M. L., & Bassendine, M. F. (2006). Microsomal triglyceride transfer protein gene promoter polymorphism (493g allele) is associated with severity of hcv-associated steatosis.. In JOURNAL OF CLINICAL VIROLOGY Vol. 36 (pp. S151). Paris, FRANCE: ELSEVIER SCIENCE BV.
DOI2006 Rygiel, K. A., Robertson, H., Burt, A. D., Jones, D. E. J., & Kirby, J. A. (2006). Demonstration of the transition of intrahepatic biliary epithelial cells to fibroblasts during chronic inflammatory liver diseases. In JOURNAL OF HEPATOLOGY Vol. 44 (pp. S241). Vienna, AUSTRIA: ELSEVIER SCIENCE BV.
DOI WoS72006 Price, D. A., Burt, A. D., Schmid, M. L., Craig, W. L., & Bassendine, M. F. (2006). Steatosis in chronic HCV infection: viral and host characteristics. In JOURNAL OF CLINICAL VIROLOGY Vol. 36 (pp. S127-S128). Paris, FRANCE: ELSEVIER SCIENCE BV.
DOI2006 Price, D. A., Schmid, M. L., Agarwal, K., Hewett, M., Craig, W. L., Burt, A. D., & Bassendine, M. F. (2006). Chronic hepatitis C in injecting drug users: a comparison with non-injecting drug users in the same geographic area. In JOURNAL OF CLINICAL VIROLOGY Vol. 36 (pp. S212). Paris, FRANCE: ELSEVIER SCIENCE BV.
DOI2005 Robertson, H., Xu, X., Burt, A. D., & Kirby, J. A. (2005). Epithelial to mesenchymal transition in chronic cholestatic liver disease. In JOURNAL OF PATHOLOGY Vol. 207 (pp. 30). Univ Newcastle upon Tyne, Med Sch, Newcastle upon Tyne, ENGLAND: JOHN WILEY & SONS LTD.
WoS12005 Burt, A. D. (2005). Vascular tumours. In JOURNAL OF PATHOLOGY Vol. 207 (pp. 58). Univ Newcastle upon Tyne, Med Sch, Newcastle upon Tyne, ENGLAND: JOHN WILEY & SONS LTD. 2005 El-Refaie, A. M. A., Agarwal, K., & Burt, A. D. (2005). Ductular reaction in early post-transplant liver biopsies: effects of immunosuppression. In JOURNAL OF PATHOLOGY Vol. 207 (pp. 29). Univ Newcastle upon Tyne, Med Sch, Newcastle upon Tyne, ENGLAND: JOHN WILEY & SONS LTD. 2005 El-Refaie, A. A., & Burt, A. D. (2005). Ductular reaction in the post-transplanted liver: a component of cellular rejection. In JOURNAL OF PATHOLOGY Vol. 205 (pp. 2). London, ENGLAND: JOHN WILEY & SONS LTD. 2005 Nielsen, S. U., Burt, A. D., Martin, C., Bassendine, M. F., & Toms, G. L. (2005). Human hepatitis C virus RNA circulates predominantly in VLDL-like lipo-viral-particles. In ATHEROSCLEROSIS Vol. 182 (pp. S6-S7). Univ Glamorgan, Pontypridd, WALES: ELSEVIER IRELAND LTD. 2005 Zhao, L., Robertson, H., Kirby, J. A., Jones, D. E. J., & Burt, A. D. (2005). Epithelial-mesenchymal transition in portal fibrosis. In JOURNAL OF PATHOLOGY Vol. 205 (pp. 1). London, ENGLAND: JOHN WILEY & SONS LTD. 2005 Xu, X., Bulmer, J. N., & Burt, A. D. (2005). Mast cells in human decidua and trophoblast: alternations in placental pathology. In JOURNAL OF PATHOLOGY Vol. 205 (pp. 5). London, ENGLAND: JOHN WILEY & SONS LTD. 2005 Malcolm, P., Mathew, J., Walker, M., & Burt, A. D. (2005). Distinctive pattern of liver histology in poorly controlled type I diabetes. In JOURNAL OF PATHOLOGY Vol. 207 (pp. 29). Univ Newcastle upon Tyne, Med Sch, Newcastle upon Tyne, ENGLAND: JOHN WILEY & SONS LTD. 2005 Nielsen, S. U., Burt, A. D., Martin, C., Bassendine, M., & Toms, G. (2005). Hepatitis C virus RNA circulates predominantly in VLDL-like lipo-viral particles. In HEPATOLOGY Vol. 42 (pp. 563A). San Francisco, CA: JOHN WILEY & SONS INC. 2005 Stark, F., Smith, D., & Burt, A. D. (2005). Pathogenesis of peribiliary gland hamartomas revisited. In JOURNAL OF PATHOLOGY Vol. 205 (pp. 17). London, ENGLAND: JOHN WILEY & SONS LTD. 2004 Price, D. A., Bassendine, M. F., Gouldin, C., Norris, S., Toms, G. L., Schmid, M. L., . . . Donaldson, P. T. (2004). Apolipoprotein E2 protects against persistent hepatitis C virus infection.. In HEPATOLOGY Vol. 40 (pp. 445A). Boston, MA: JOHN WILEY & SONS INC. 2004 Stewart, S. F., Jones, D. E. J., Vidali, M., Haugk, B., Burt, A. D., Albano, E., & Day, C. P. (2004). Correlation between anti-CYP2E1 titre and lymphocyte infiltration in ALD - An autoimmune disease in some patients?. In JOURNAL OF HEPATOLOGY Vol. 40 (pp. 176-177). Berlin, GERMANY: ELSEVIER SCIENCE BV.
DOI WoS42004 Price, D. A., Burt, A. D., Turner, A., Craig, W. L., Schmid, M. L., & Bassendine, M. F. (2004). Host and viral characteristics associated with steatosis in chronic hepatitis C. In GUT Vol. 53 (pp. A82-A83). Glasgow, Scotland: B M J PUBLISHING GROUP. 2004 Zhao, L., & Burt, A. D. (2004). Expansion of hepatic stellate cell populations occurs in response to primary and metastatic liver tumours. In JOURNAL OF PATHOLOGY Vol. 204 (pp. 8A). Vrije Univ Med Ctr, Dept Pathol, Amstedram, NETHERLANDS: JOHN WILEY & SONS LTD. 2003 Stewart, S. F., Daly, A. K., Chen, Y., Leathart, J. B., Haugk, B., Jones, D. E. J., . . . Day, C. P. (2003). Evidence that alcoholic liver disease is due to immune mechanisms in genetically susceptible drinkers. In GUT Vol. 52 (pp. 2 pages). NEWCASTLE, ENGLAND: BRITISH MED JOURNAL PUBL GROUP. 2003 Nielson, S. U., Burt, A. D., Martin, C., Bassendine, M. F., & Toms, G. L. (2003). Association of HCV particles with LDL/VLDL: Analysis using isotonic iodixanol gradient centrifugation & real time PCR.. In HEPATOLOGY Vol. 38 (pp. 670A-671A). BOSTON, MASSACHUSETTS: W B SAUNDERS CO. 2003 Albano, E., Mottaran, E., Vidali, M., Reale, E., Saksena, S., Occhino, G., . . . Day, C. P. (2003). Oxidative stress is an independent risk factor for the progression of non-alcoholic fatty liver disease (NAFLD) to advanced fibrosis.. In HEPATOLOGY Vol. 38 (pp. 506A). BOSTON, MASSACHUSETTS: W B SAUNDERS CO. 2003 Hicks, A. E. R., Burt, A. D., Thompson, M. G., & Day, C. P. (2003). Bile acids have a direct effect on collagen biosynthesis by hepatic stellate cells. In GUT Vol. 52 (pp. 2 pages). NEWCASTLE, ENGLAND: BRITISH MED JOURNAL PUBL GROUP. 2003 Zhao, L., & Burt, A. D. (2003). Neural and muscle proteins in hepatic stellate cells and mesenchymal cells of other mammalian tissues. In JOURNAL OF PATHOLOGY Vol. 201 (pp. 22A). UNIV BRISTOL, BRISTOL, ENGLAND: JOHN WILEY & SONS LTD. 2003 Igbokwe, U. O., Gould, D. J., Burt, A. D., & Mathew, J. (2003). Methotrexate, psoriasis and α<sub>1</sub>-antitrypsin deficiency:: a cocktail for liver fibrosis?. In JOURNAL OF PATHOLOGY Vol. 201 (pp. 20A). UNIV BRISTOL, BRISTOL, ENGLAND: JOHN WILEY & SONS LTD. 2003 El-Refaie, A. M. A., & Burt, A. D. (2003). Mast cells in liver allograft rejection. In JOURNAL OF PATHOLOGY Vol. 201 (pp. 22A). UNIV BRISTOL, BRISTOL, ENGLAND: JOHN WILEY & SONS LTD. 2003 Leong, M. Y., Burt, A. D., Gould, D. J., Bowers, P. W., & Mathew, J. (2003). Haemochromatosis and methotrexate: inviting liver fibrosis?. In JOURNAL OF PATHOLOGY Vol. 201 (pp. 20A). UNIV BRISTOL, BRISTOL, ENGLAND: JOHN WILEY & SONS LTD. 2003 Price, D. A., Agawal, K., Hewett, M., Craig, W. L., Schmid, M., Turner, A., . . . Bassendine, M. F. (2003). The hepatitis C virus (HCV) epidemic; spectrum of chronic liver disease in a single UK centre. In GUT Vol. 52 (pp. 1 page). NEWCASTLE, ENGLAND: BRITISH MED JOURNAL PUBL GROUP. 2003 Saksena, S., Leathart, J. B., Burt, A. D., James, O. F. W., Daly, A. K., & Day, C. P. (2003). Genetic evidence supporting the two-hit model of NASH pathogenesis. In GUT Vol. 52 (pp. 1 page). NEWCASTLE, ENGLAND: BRITISH MED JOURNAL PUBL GROUP. 2002 Crompton, D. E., Chinnery, P. F., Fey, C., Curtis, A. R. J., Morris, C. M., Kierstan, J., . . . Burn, J. (2002). Neuroferritinopathy: A window on the role of iron in neurodegeneration. In Blood cells, molecules & diseases Vol. 29 (pp. 522-531). CHIEMESEE, GERMANY: ACADEMIC PRESS INC ELSEVIER SCIENCE.
DOI Scopus72 WoS62 Europe PMC452002 Hicks, A. E., Burt, A. D., Thompson, M. G., & Day, C. P. (2002). Bile acids have a direct effect on collagen biosynthesis by hepatic stellate cells.. In HEPATOLOGY Vol. 36 (pp. 485A). BOSTON, MASSACHUSETTS: W B SAUNDERS CO. 2002 Price, A., Agawal, K., Hewett, M., Craig, W. L., Schmid, M., Turner, A., . . . Bassendine, M. F. (2002). The hepatitis C virus (HCV) epidemic; Spectrum of chronic liver disease in a single UK centre.. In HEPATOLOGY Vol. 36 (pp. 554A). BOSTON, MASSACHUSETTS: W B SAUNDERS CO. 1997 Dack, C. L., Day, C. P., Johnson, S. J., & Burt, A. D. (1997). Population kinetics of GFAP-positive cells following experimental acute liver injury. In E. Wisse, D. L. Knook, & C. Balabaud (Eds.), CELLS OF THE HEPATIC SINUSOID, VOL 6 (pp. 59-61). BORDEAUX, FRANCE: KUPFFER CELL FOUNDATION.
WoS21997 Reeves, H. L., Dack, C. L., Day, C. P., & Burt, A. D. (1997). β<sub>1</sub> Integrin expression in hepatic stellate cells from normal and diseased human livers. In E. Wisse, D. L. Knook, & C. Balabaud (Eds.), CELLS OF THE HEPATIC SINUSOID, VOL 6 (pp. 154-155). BORDEAUX, FRANCE: KUPFFER CELL FOUNDATION.
WoS21994 BURT, A. D., & MATHEW, J. (1994). CELL-CELL AND CELL-MATRIX INTERACTIONS IN HEPATOCARCINOGENESIS. In G. Tiniakos (Ed.), PROGRESS IN HEPATOLOGY '94 (pp. 73-80). ATHENS, GREECE: BETA MEDICAL PUBLISHERS LTD.
WoS11993 HINES, J. E., & BURT, A. D. (1993). EXPRESSION OF CELLULAR INTEGRINS AND THEIR LIGANDS IN HUMAN LIVER SINUSOIDS DURING ONTOGENY. In D. L. Knook, & E. Wisse (Eds.), CELLS OF THE HEPATIC SINUSOID, VOL 4 (pp. 574-577). KUPFFER CELL FDN, ANTWERP, BELGIUM: KUPFFER CELL FOUNDATION.
WoS11993 MATHEW, J., & BURT, A. D. (1993). CELLULAR MECHANISMS OF FIBROGENESIS IN GENETIC HEMOCHROMATOSIS. In D. L. Knook, & E. Wisse (Eds.), CELLS OF THE HEPATIC SINUSOID, VOL 4 (pp. 274-276). KUPFFER CELL FDN, ANTWERP, BELGIUM: KUPFFER CELL FOUNDATION.
WoS11992 MATHEW, J., JAMES, O. F. W., HINES, J. E., & BURT, A. D. (1992). QUANTITATIVE-ANALYSIS OF THE PERISINUSOIDAL CELL AND MACROPHAGE RESPONSE TO ACETAMINOPHEN-INDUCED LIVER-INJURY. In A. M. GRESSNER, & G. RAMADORI (Eds.), MOLECULAR AND CELL BIOLOGY OF LIVER FIBROGENESIS (pp. 358-360). MARBURG, GERMANY: KLUWER ACADEMIC PUBL.
WoS11992 JOHNSON, S. J., HILLAN, K. J., HINES, J. E., FERRIER, R., & BURT, A. D. (1992). PROLIFERATION AND PHENOTYPIC MODULATION OF PERISINUSOIDAL (ITO) CELLS FOLLOWING ACUTE LIVER-INJURY - TEMPORAL RELATIONSHIP WITH TGF-BETA-1 EXPRESSION. In B. CLEMENT, & A. GUILLOUZO (Eds.), CELLULAR AND MOLECULAR ASPECTS OF CIRRHOSIS Vol. 216 (pp. 219-222). RENNES, FRANCE: INSERM / JOHN LIBBEY EUROTEXT.
WoS101991 BURR, A. W., JOHNSON, S. J., CARPENTER, M. R., & BURT, A. D. (1991). IMMUNOLOCALIZATION OF TRANSFORMING GROWTH FACTOR-ALPHA (TGF-ALPHA) IN REGENERATING LIVER FOLLOWING CHEMICALLY-INDUCED NECROSIS. In K. W. WOODHOUSE, & M. S. OMAHONY (Eds.), DRUG METABOLISM, LIVER INJURY AND AGEING Vol. 16 (pp. 203-210). CARDIFF, WALES: EURAGE BOOK SERVICE. 1991 AHMED, Q., HINES, J. E., HARRISON, D., & BURT, A. D. (1991). EXPRESSION OF MUSCLE-ASSOCIATED CYTOSKELETAL PROTEINS BY HUMAN SINUSOIDAL LIVER-CELLS. In E. WISSE, D. L. KNOOK, & R. S. MCCUSKEY (Eds.), CELLS OF THE HEPATIC SINUSOID, VOL 3 (pp. 203-206). TUCSON, AZ: KUPFFER CELL FOUNDATION.
WoS51991 GRIFFITHS, M. R., FERRIER, R., SCHUPPAN, D., & BURT, A. D. (1991). COLLAGEN TYPE-VI - A COMPONENT OF THE PERISINUSOIDAL EXTRACELLULAR-MATRIX IN HUMAN LIVER. In E. WISSE, D. L. KNOOK, & R. S. MCCUSKEY (Eds.), CELLS OF THE HEPATIC SINUSOID, VOL 3 (pp. 155-160). TUCSON, AZ: KUPFFER CELL FOUNDATION. 1991 MATHEW, J., WYNNE, H., CATTAN, A. R., HALL, A. G., & BURT, A. D. (1991). EXPRESSION OF GLUTATHIONE S-TRANSFERASES IN THE AGING LIVER. In K. W. WOODHOUSE, & M. S. OMAHONY (Eds.), DRUG METABOLISM, LIVER INJURY AND AGEING Vol. 16 (pp. 173-180). CARDIFF, WALES: EURAGE BOOK SERVICE. 1991 HINES, J. E., JOHNSON, S. J., & BURT, A. D. (1991). NONPARENCHYMAL CELL RESPONSES DURING THE DEVELOPMENT OF BILIARY-CIRRHOSIS. In K. W. WOODHOUSE, & M. S. OMAHONY (Eds.), DRUG METABOLISM, LIVER INJURY AND AGEING Vol. 16 (pp. 211-217). CARDIFF, WALES: EURAGE BOOK SERVICE. 1991 BURT, A. D., AHMED, Q., HINES, J. E., & LEE, J. A. (1991). INNERVATION OF HUMAN HEPATIC SINUSOIDS - ALTERATIONS IN LIVER-DISEASE. In E. WISSE, D. L. KNOOK, & R. S. MCCUSKEY (Eds.), CELLS OF THE HEPATIC SINUSOID, VOL 3 (pp. 92-97). TUCSON, AZ: KUPFFER CELL FOUNDATION.
WoS21986 GOUDIE, B. M., BURT, A. D., MACFARLANE, G., BOYLE, P., MACSWEEN, R. N. M., & WATKINSON, G. (1986). FACTORS AFFECTING THE PROGNOSIS OF PRIMARY BILIARY-CIRRHOSIS. In GUT Vol. 27 (pp. A622). BRITISH MED JOURNAL PUBL GROUP. -
Conference Items
Year Citation 2019 Pu, L. Z. C. T., Chiam, K., Yamamura, T., Nakamura, M., Berzin, T., Mir, F., . . . Singh, R. (2019). Narrow-band imaging for scar (NBI-SCAR) classification: From conception to multicenter validation. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. 2018 Pu, L. Z. C. T., Yamamura, T., Nakamura, M., Koay, D. S. C., Ovenden, A., Edwards, S., . . . Singh, R. (2018). Prospective study predicting histology in colorectal lesions using wNICE, wJNET, and MS classifications. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. 2018 Pu, L. Z. C. T., Ovenden, A., Nakamura, M., Yamamura, T., Sawada, T., Koay, D. S. C., . . . Singh, R. (2018). Prospective study assessing associated factors in patients with colorectal lesions. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. 2018 Pu, L. Z. C. T., Lu, K., Ovenden, A., Rana, K., Singh, G., Krishnamurthi, S., . . . Singh, R. (2018). Effect of training and time of the day on polyp detection rates. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. 2018 Pu, L. Z. C. T., Singh, G., Krishnamurthi, S., Ovenden, A., Nakamura, M., Yamamura, T., . . . Singh, R. (2018). Prevalence and distribution of serrated polyps in the colon. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. 2017 Houghton, D., Zalewski, P., Cassidy, S., Thoma, C., Hallsworth, K., Avery, L., . . . Trenell, M. I. (2017). Autonomic function is impaired across the spectrum of NAFLD. Poster session presented at the meeting of JOURNAL OF HEPATOLOGY. Amsterdam, NETHERLANDS: ELSEVIER SCIENCE BV.
DOI2017 Pu, L., Koay, D., Ovenden, A., Burt, A., & Singh, R. (2017). Prospective study assessing associated factors in patients with colon polyps: Interim analysis. Poster session presented at the meeting of Abstracts of the annual scientific meeting of the Gastroenterological Society of Australia, Australian Gastroenterology Week (GESA AGW 2017), as published in Journal of Gastroenterology and Hepatology. Gold Coast, QLD: Wiley.
DOI2017 Cheng, L. Z. T. P., Siew, D. C. K., Ovenden, A., Burt, A. D., & Singh, R. (2017). Prospective study to evaluate scars after colorectal EMR using NBI with dual focus and underwater technique (uNBI-DF): Interim analysis. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. 2017 Cheng, L. Z. T. P., Campbell, B., Carneiro, G., Burt, A. D., & Singh, R. (2017). Computer-aided diagnosis (CAD) for characterising colorectal lesions: Initial results of a newly developed software. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. 2017 Cheng, L. Z. T. P., Siew, D. C. K., Ovenden, A., Burt, A. D., & Singh, R. (2017). Prospective study predicting histology in colorectal lesions: Interim analysis of the NICE, JNET and MS classifications. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY.
WoS12017 Cheng, L. Z. T. P., Siew, D. C. K., Ovenden, A., Burt, A. D., & Singh, R. (2017). Prospective study assessing associated factors in patients with colon polyps: interim analysis. Poster session presented at the meeting of Abstracts of the Asian Pacific Digestive Week (APDW). The Future in Digestive Diseases, as published in Journal of Gastroenterology and Hepatology. Hong Kong: Wiley.
DOI WoS12015 Mcpherson, S., Hardy, T., Henderson, E., Allison, M., Ratziu, V., Francque, S., . . . Anstee, Q. M. (2015). HIGH RATE OF FALSE POSITIVES FOR ADVANCED FIBROSIS WHEN SIMPLE NON-INVASIVE FIBROSIS TESTS ARE USED IN OLDER PATIENTS (≥ 65 YEARS) WITH NAFLD. Poster session presented at the meeting of GUT. London, ENGLAND: BMJ PUBLISHING GROUP.
DOI2014 McPherson, S., Henderson, E., Hardy, T., Burt, A. D., Day, C., & Anstee, Q. M. (2014). Natural history of NAFLD: A study of 108 patients with paired liver biopsies. Poster session presented at the meeting of HEPATOLOGY. Boston, MA: WILEY-BLACKWELL. 2013 Patman, G. L., Televantou, D., Whitehead, A., Day, C. P., Oakley, F., Mann, D. A., . . . Reeves, H. L. (2013). MILD STEATOSIS AND IMPAIRED GLUCOSE TOLERANCE ARE ASSOCIATED WITH LIVER CANCER DEVELOPMENT, WHILE PROGRESSION TO NASH INCREASES NUMBER/SIZE IN AN ANIMAL MODEL OF NAFLD. Poster session presented at the meeting of JOURNAL OF HEPATOLOGY. Amsterdam, NETHERLANDS: ELSEVIER SCIENCE BV.
DOI2013 Brain, J. G., Masson, S., & Burt, A. D. (2013). Transplantation for ALD: Lessons From the Explant. Poster session presented at the meeting of JOURNAL OF PATHOLOGY. Univ Edinburgh, Div Pathol, Edinburgh, SCOTLAND: WILEY-BLACKWELL. 2013 Patman, G. L., Televantou, D., Whitehead, A., Piguet, A. -C., Dufour, J. F., Day, C. P., . . . Reeves, H. L. (2013). SULFATASE-2 (SULF2) EXPRESSED IN HEPATOCYTES AND STROMAL CELLS CONTRIBUTES TO THE DEVELOPMENT OF STEATOSIS, THE PROGRESSION OF NAFLD TO FIBROSIS AND THE ADVANCEMENT OF CANCER. Poster session presented at the meeting of JOURNAL OF HEPATOLOGY. Amsterdam, NETHERLANDS: ELSEVIER SCIENCE BV.
DOI2013 Whitehead, A., Patman, G. L., Cornell, L., Televantou, D., Curtin, N., Day, C. P., . . . Reeves, H. L. (2013). A ROLE FOR DNA REPAIR PROTEIN KINASE (DNA-PK) IN THE PROGRESSION OF SIMPLE STEATOSIS TO STEATOHEPATITIS (NASH)?. Poster session presented at the meeting of JOURNAL OF HEPATOLOGY. Amsterdam, NETHERLANDS: ELSEVIER SCIENCE BV.
DOI2013 Probert, P. M. E., Ebrahimkhani, M. R., Oakley, F., Burt, A. D., Mann, D. A., & Wright, M. C. (2013). METHAPYRILENE TREATMENT IS A REFINED ALTERNATIVE TO BILE DUCT LIGATION AS A MODEL OF REPRODUCIBLE AND REVERSIBLE PERIPORTAL FIBROSIS IN THE RAT. Poster session presented at the meeting of JOURNAL OF HEPATOLOGY. Amsterdam, NETHERLANDS: ELSEVIER.
DOI2013 Rutkowski, J. V., Burt, A. D., Leavitt, M. C., Hu, W., Canty, D., & Quinn, A. G. (2013). Co-localization of macrophage aggregation and fibrosis in a rat model of lysosomal acid lipase (LAL) deficiency and the effects of enzyme replacement with SBC-102. Poster session presented at the meeting of MOLECULAR GENETICS AND METABOLISM. Orlando, FL: ACADEMIC PRESS INC ELSEVIER SCIENCE.
DOI WoS22012 Trembling, P. M., Parkes, J., Tanwar, S., Burt, A. D., & Rosenberg, W. M. (2012). ENHANCED LIVER FIBROSIS TEST ACCURATELY IDENTIFIES LIVER FIBROSIS AND PREDICTS CLINICAL OUTCOMES IN ALCOHOLIC LIVER DISEASE. Poster session presented at the meeting of GUT. B M J PUBLISHING GROUP.
DOI2012 Rutkowski, J., Burt, A. D., Leavitt, M., Hu, W., Canty, D., & Quinn, A. G. (2012). Recombinant Human Lysosomal Acid Lipase Decreases Hepatic Macrophage Aggregates and Colocalized Fibrosis in a Rat Model of Lysosomal Acid Lipase Deficiency. Poster session presented at the meeting of HEPATOLOGY. Boston, MA: WILEY-BLACKWELL.
WoS32012 Robinson, S. M., Mann, J., Burt, A. D., Manas, D. M., Mann, D. A., & White, S. A. (2012). Does a pro-thrombotic environment contribute to the development of chemotherapy associated liver injury in patients with colorectal liver metastases?. Poster session presented at the meeting of Abstracts from the Annual Meeting of the Society of Academic and Research Surgery, as published in British Journal of Surgery. Nottingham, England: WILEY-BLACKWELL.
DOI2012 Televantou, D., Hui, K. Y. D., Lochan, R., Charnley, R., Burt, A. D., & Reeves, H. L. (2012). MEMBRANOUS EXPRESSION OF SULFATASE-2 IS ASSOCIATED WITH A POORER PROGNOSIS IN PATIENTS FOLLOWING PANCREATIC CANCER RESECTION. Poster session presented at the meeting of GUT. B M J PUBLISHING GROUP.
DOI2012 Tanwar, S., Trembling, P. M., Hogan, B. J., Thorburn, D., Guha, I. N., Parkes, J., . . . Rosenberg, W. M. (2012). An algorithm combining direct and indirect liver fibrosis tests enhances diagnostic performance for the detection of advanced fibrosis (F3-4) in NAFLD minimising the need for liver biopsy. Poster session presented at the meeting of HEPATOLOGY. Boston, MA: WILEY-BLACKWELL.
WoS12012 Robinson, S. M., Koshy, A., Knisely, A., Manas, D. M., Burt, A. D., & White, S. A. (2012). Biliary dysfunction in patients with sinusoidal obstruction syndrome. Poster session presented at the meeting of Abstracts from the Annual Meeting of the Society of Academic and Research Surgery, as published in British Journal of Surgery. Nottingham, England: Wiley-Blackwell.
DOI2012 Masson, S., Emmerson, I., Henderson, E., Fletcher, E., Burt, A. D., Day, C. P., & Stewart, S. F. (2012). Clinical but not histological factors predict long-term prognosis in patients with biopsy proven advanced alcoholic liver disease. Poster session presented at the meeting of Abstracts of The International Liver Congress™ 2012 – 47th annual meeting of the European Association for the Study of the Liver, as published in Journal of Hepatology. Barcelona, Spain: Elsevier Ireland.
DOI2012 Brain, J. G., Thompson, E., Burt, A. D., & Kirby, J. A. (2012). Allografts, Immunosupression and Autophagy: A Conspiracy to Fibrose?. Poster session presented at the meeting of JOURNAL OF PATHOLOGY. Univ Sheffield, Acad Unit Pathol, Sheffield, ENGLAND: WILEY-BLACKWELL. 2012 Trembling, P. M., Parkes, J., Tanwar, S., Burt, A. D., & Rosenberg, W. M. (2012). Enhanced liver fibrosis test accurately identifies liver fibrosis and predicts clinical outcomes in alcoholic liver disease. Poster session presented at the meeting of Abstracts of The International Liver Congress™ 2012 – 47th annual meeting of the European Association for the Study of the Liver, as published in Journal of Hepatology. Barcelona, Spain: Elsevier Ireland.
DOI WoS22012 Anstee, Q. M., Darlay, R., Leathart, J. B., Clement, J., Clement, K., Aithal, G. P., . . . Day, C. P. (2012). Genome-Wide Association Analysis Confirms Importance of PNPLA3 and Identifies Novel Variants Associated With Histologically Progressive Steatohepatitis in NAFLD. Poster session presented at the meeting of HEPATOLOGY. Boston, MA: WILEY-BLACKWELL.
WoS72012 Dunn, L. J., Shenfine, J., Burt, A. D., Jankowski, J. A., & Griffin, S. M. (2012). Columnar metaplasia in the oesophageal remnant following oesophagectomy - a common occurrence and a valuable insight into the development of Barrett's oesophagus. Poster session presented at the meeting of Abstracts from the International Surgical Congress of the Association-of-Surgeons-of-Great-Britain-and-Ireland (ASGBI),as published in British Journal of Surgery. Liverpool, ENGLAND: Wiley-Blackwell.
DOI2012 Robinson, S. M., Mann, J., Manas, D. M., Burt, A. D., Mann, D. A., & White, S. A. (2012). An experimental model of FOLFOX-induced sinusoidal obstruction syndrome.. Poster session presented at the meeting of JOURNAL OF CLINICAL ONCOLOGY. United States: AMER SOC CLINICAL ONCOLOGY.
DOI1994 BURT, A. D., HILLAN, K. J., MCLAUGHLIN, K. E., CHAPMAN, C., MATHEW, J., & BURR, A. W. (1994). HEPATOCYTE GROWTH-FACTOR LEVELS IN LIVER AND SERUM INCREASE DURING CHEMICAL HEPATOCARCINOGENESIS. Poster session presented at the meeting of HEPATOLOGY. W B SAUNDERS CO. 1992 Lee, J. A., Boon, A. P., Hubscher, S. G., Hines, J. E., & Burt, A. D. (1992). Hepatic reinnervation following orthotopic liver transplantation in man. Poster session presented at the meeting of Journal of Physiology. CAMBRIDGE UNIV PRESS. -
Preprint
Year Citation 2021 Tian, Y., Pu, L. Z. C. T., Liu, Y., Maicas, G., Verjans, J. W., Burt, A. D., . . . Carneiro, G. (2021). Detecting, Localising and Classifying Polyps from Colonoscopy Videos using Deep Learning..
| Date | Grant | Amount |
|---|---|---|
| October 1986 | Scottish Home and Health Department Grant K/MRS/50/C956 - Extracellular matrix protein synthesis in the human liver | £56,000 |
| November 1986 | Tenovus (Scotland) - The role of sinusoidal cells in protein biosynthesis by the mammalian liver | £10,000 |
| November 1986 | Kinnear Brown Trust - Towards purchase of Beckman JE-6B elutriator rotor centrifuge | £11,000 |
| July 1988 | Scottish Home and Health Department Biomedical Research Committee Extracellular matrix protein synthesis in the liver | £26,000 |
| December 1989 | Newcastle Health Authority Research Committee - Role of transforming growth factor in the response of fat strong cells to liver injury and the induction of experimental hepatic fibrosis | £13,976 |
| April 1990 | North of England Cancer Research Campaign - Cellular origin of hepatocyte growth factor in liver regeneration and during hepatocarcinogenesis | £46,896 |
| May 1990 | University Research Committee - Production of monoclonal antibodies to rat liver perisinusoidal cells | £6,635 |
| August 1990 | Newcastle University Hospital Special Trustees - Intracellular ion measurements for the investigation of cellular pathology | £35,566 |
| September 1990 | University (Small Grants) Awards - Localisation of peptide growth factors in normal and fibrotic human liver | £658 |
| March 1991 | Newcastle Health Authority Research Committee - Alterations to intra-hepatic nerves in chronic liver disease and orthotopic liver allografts | £15,133 |
| May 1991 | North of England Cancer Research Campaign - Cell-matrix interactions in hepato- carcinogenesis | £37,550 |
| July 1991 | North of England Cancer Research Campaign - DNA repair by O6-methyl guanine DNA methyl transferase: its role in human hepatocarcinogenesis | £104,058 |
| November 1992 | North of England Cancer Research Campaign - Modulation of cell proliferation in vivo using monoclonal anti-growth factor antibodies | £78,697 |
| November 1992 | Northern Regional Health Authority - Quantitative assessment of hepatic fibrosis in percutaneous liver biopsy specimens | £16,079 |
| June 1993 | University Hospital Special Trustees - Risk stratification in hereditary non-polyposis colorectal cancer | £30,647 |
| August 1993 | University Hospitals Trustees -Integrins and cadherins as prognostic indicators in breast cancer | £18,100 |
| February 1994 | MRC Clinical Training Fellowship (for Dr. S. Hinchliffe) - Expression of androgen receptor in human malignancies: molecular pathological studies |
£33,075 |
| April 1994 | Northern Regional Health Authority - In situ PCR: application to hepatitis C virus infection | £25,000 |
| April 1994 | Wellbeing/Royal College of Obstetricians and Gynaecologists - The pulmonary interstitium in normal development and bronchopulmonary dysplasia |
£23,594 |
| June 1994 | Medical Research Council Collaborative PhD Studentship - Modulation of the function of hepatocyte growth factor and its receptor in vivo using antibodies to recombinant proteins | £35,000 |
| June 1994 | Luccock Faculty Studentship - Cell-matrix interactions and signal transduction pathways in liver perisinusoidal (Ito) cells | £24,000 |
| May 1995 | North of England Cancer Research Campaign - Alkylation DNA damage and repair | £71,000 |
| June 1995 | British Lung Foundation - Cell proliferation and programmed cell death in the early human lung development | £21,720 |
| June 1995 | University Hospital Special Trustees - Endothelin 1 and endothelin receptors in alcoholic liver disease | £21,000 |
| July 1995 | National Institute of Health (USA) (with Dr JN Bulmer) - Preterm labor: an immune phenomenon? | £48,000 |
| February 1996 | Freeman Hospital Trustees - Endothelial damage after liver perfusion | £1,718 |
| February 1996 | Bayer Pharmaceuticals - In vivo inhibition of growth factor activity following injury: image bullets and fibrogenesis | £34,700 |
| January 1998 | Bayer Pharmaceuticals -Serum markers of liver fibrosis | £109,889 |
| July 1998 | National Kidney Research Fund - Renal allograft rejection: examination of the basis for tissue specific cytotoxicity | £75,000 |
| January 1999 | University Hospital Special Trustees - Cell signalling in hepatic stellate cells: role of lipid second messengers | £9,700 |
| February 1999 | Harker Foundation - Bile duct destruction in autoimmune cholangiopathy | £37,500 |
| June 2000 | Wellcome Trust- Biochemical and functional characterisation of hepatitis C virus particles isolated from human liver and serum | £163,593 |
| August 2000 | William Harker Foundation - Do apoptotic biliary epithelial cells provide the antigen for induction of autoimmune cholangiopathy? | £53,876 |
| August 2001 | Cancer Research Campaign - Lymphatic mapping and sentinel node biopsy in the evaluation of the metastatic dissemination of oesophageal adenocarcinoma | £43,169 |
| February 2001 | Children’s Liver Disease Foundation - The role of bile acids in the regulation of hepatic stellate cell function | £75,067 |
| April 2001 | Medical Research Council - Use of multiple epidemiological methods to examine clues to environmental causative factors in primary biliary cirrhosis | £128,221 |
| December 2002 |
Newcastle Healthcare Charity - Novel mechanisms of progressive allograft dysfunction |
£9,100 |
| June 2003 | Roche Organ Transplant Research Foundation - Therapeutic elimination of intraepithelial T cells: a strategy to reduce epithelial-mesenchymal transdifferentiation and chronic allograft dysfunction | £125,424 |
| January 2004 | National Association for Crohn’s Disease and Colitis - Histological correlation with genetic variation in Crohn’s disease |
£38,000 |
| February 2007 | National Kidney Research Fund - Kidney allograft failure: implications of the imbalance between IL-17 and TGFβ producing intratubular cells | £112,070 |
| April 2008 | Newcastle Healthcare Charity - Pilot study of the use of antibody to surface proteins on hepatic myofibroblasts in fibrosis imaging | £24,725 |
| October 2008 | Wellcome Trust - Role of myofibroblasts in liver injury and regeneration | £263,000 |
| January 2009 | European Commission FP7 - INFLA-CARE Understanding inflammation associated for the rational decision of novel anti-cancer | 554,592 euros |
| July 2009 | European Commission FP7 - Fatty Liver Inhibition of Progression (FLIP) European Fatty Liver CRN | 5.9 million euros |
| July 2009 | Wellcome Trust Programme Grant - Innate immunity and liver fibrosis (Co-PI with Michael Karin and Derek Mann | £690,415 |
| Jan 2015 | NHMRC – The role of TRPM2 channels in oxidative stress induced liver damage | $558,433 |
-
Past Higher Degree by Research Supervision (University of Adelaide)
Date Role Research Topic Program Degree Type Student Load Student Name 2016 - 2020 Principal Supervisor Endoscopy-Focused Primary, Secondary and Tertiary Prevention of Colorectal Cancer Doctor of Philosophy under a Jointly-awarded Degree Agreement with Doctorate Full Time Dr Leonardo Zorron Cheng Tao Pu 2016 - 2021 Co-Supervisor The Roles of Cancer-Associated Fibroblasts in Colorectal Carcinogenesis Doctor of Philosophy under a Jointly-awarded Degree Agreement with Doctorate Full Time Mr Hiroki Kobayashi
-
Memberships
Date Role Membership Country 2015 - ongoing Member Australian Academy of Health and Medical Sciences Australia 1991 - ongoing Member Member of the Institute of Biologists - 1988 - ongoing Member Membership of Royal College of Pathologists United Kingdom
Connect With Me
External Profiles
